<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">96907</article-id><article-id pub-id-type="doi">10.7554/eLife.96907</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.96907.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Dysfunction of Calcyphosine-Like gene impairs retinal angiogenesis through the MYC axis and is associated with familial exudative vitreoretinopathy</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Wenjing</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8037-6275</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Shujin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yang</surname><given-names>Mu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6001-6827</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ma</surname><given-names>Jie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3746-4381</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Fei</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Qianchun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Lulin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1204-5957</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhao</surname><given-names>Peiquan</given-names></name><email>zhaopeiquan@xinhuamed.com.cn</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yang</surname><given-names>Zhenglin</given-names></name><email>yangzhenglin@cashq.ac.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhu</surname><given-names>Xianjun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2531-7552</contrib-id><email>xjzhu2@126.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04qr3zq92</institution-id><institution>The Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for The Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for Medical Genetics, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04w5etv87</institution-id><institution>Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03f72zw41</institution-id><institution>Henan Branch of National Clinical Research Center for Ocular Diseases, Henan Eye Hospital, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Zhengzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220qvk04</institution-id><institution>Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution>Jinfeng Laboratory</institution><addr-line><named-content content-type="city">Chongqing</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01qh26a66</institution-id><institution>Research Unit for Blindness Prevention of Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Liu</surname><given-names>Xiaorong</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0153tk833</institution-id><institution>University of Virginia</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Smith</surname><given-names>Lois EH</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00dvg7y05</institution-id><institution>Boston Children's Hospital</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>12</day><month>09</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP96907</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-02-19"><day>19</day><month>02</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-02-24"><day>24</day><month>02</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.22.24303109"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-04-10"><day>10</day><month>04</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96907.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-08-02"><day>02</day><month>08</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96907.2"/></event></pub-history><permissions><copyright-statement>© 2024, Liu, Li, Yang et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Liu, Li, Yang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-96907-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-96907-figures-v1.pdf"/><abstract><p>Familial exudative vitreoretinopathy (FEVR) is a severe genetic disorder characterized by incomplete vascularization of the peripheral retina and associated symptoms that can lead to vision loss. However, the underlying genetic causes of approximately 50% of FEVR cases remain unknown. Here, we report two heterozygous variants in calcyphosine-like gene (<italic>CAPSL</italic>) that is associated with FEVR. Both variants exhibited compromised CAPSL protein expression. Vascular endothelial cell (EC)-specific inactivation of <italic>Capsl</italic> resulted in delayed radial/vertical vascular progression, compromised endothelial proliferation/migration, recapitulating the human FEVR phenotypes. <italic>CAPSL</italic>-depleted human retinal microvascular endothelial cells (HRECs) exhibited impaired tube formation, decreased cell proliferation, disrupted cell polarity establishment, and filopodia/lamellipodia formation, as well as disrupted collective cell migration. Transcriptomic and proteomic profiling revealed that <italic>CAPSL</italic> abolition inhibited the MYC signaling axis, in which the expression of core MYC targeted genes were profoundly decreased. Furthermore, a combined analysis of <italic>CAPSL</italic>-depleted HRECs and <italic>c-MYC</italic>-depleted human umbilical vein endothelial cells uncovered similar transcription patterns. Collectively, this study reports a novel FEVR-associated candidate gene, <italic>CAPSL</italic>, which provides valuable information for genetic counseling of FEVR. This study also reveals that compromised CAPSL function may cause FEVR through MYC axis, shedding light on the potential involvement of MYC signaling in the pathogenesis of FEVR.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>angiogenesis</kwd><kwd>familial exudative vitreoretinopathy</kwd><kwd>CAPSL</kwd><kwd>MYC</kwd><kwd>knockout models</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82371083</award-id><principal-award-recipient><name><surname>Zhu</surname><given-names>Xianjun</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82121003</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Zhenglin</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012542</institution-id><institution>Sichuan Province Science and Technology Support Program</institution></institution-wrap></funding-source><award-id>2023ZYD0172</award-id><principal-award-recipient><name><surname>Zhu</surname><given-names>Xianjun</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Sichuan Provincial People’s Hospital Postdoctoral fund</institution></institution-wrap></funding-source><award-id>2022BH019</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Wenjing</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Sichuan Provincial People’s Hospital Huanhua Talent program</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zhu</surname><given-names>Xianjun</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82101153</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Mu</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>CAMS Innovation Fund for Medical Sciences</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Yang</surname><given-names>Zhenglin</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>Sichuan Intellectual Property Office (China)</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zhu</surname><given-names>Xianjun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genetic analysis and knockout mouse model study identified calcyphosine-like (CAPSL) as a candidate disease gene in familial exudative vitreoretinopathy (FEVR), offering valuable insights into disease mechanisms.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>A well-organized vascular system is crucial for the proper development of most tissue and organ morphogenesis (<xref ref-type="bibr" rid="bib76">Vogenstahl et al., 2022</xref>; <xref ref-type="bibr" rid="bib82">Ye et al., 2009</xref>). Consequently, angiogenic defects have been associated with several congenital human diseases (<xref ref-type="bibr" rid="bib9">Carmeliet and Jain, 2011</xref>; <xref ref-type="bibr" rid="bib25">Fallah et al., 2019</xref>). Familial exudative vitreoretinopathy (FEVR) is a heritable vitreoretinopathy characterized by defective retinal angiogenesis and various complications, such as extensive neovascularization, exudation, retinal folds and detachments, and vision loss (<xref ref-type="bibr" rid="bib83">Yonekawa et al., 2015</xref>). Based on an ocular screening of over 60,000 Chinese newborns, the estimated prevalence of FEVR is around 0.46% (<xref ref-type="bibr" rid="bib26">Fei et al., 2021</xref>). Due to the significant genetic heterogeneity, FEVR displays all Mendelian forms of inheritance: autosomal dominant (AD), autosomal recessive (AR), or X-linked recessive (XR) (<xref ref-type="bibr" rid="bib62">Plager et al., 1992</xref>; <xref ref-type="bibr" rid="bib34">Gow and Oliver, 1971</xref>; <xref ref-type="bibr" rid="bib21">de Crecchio et al., 1998</xref>). To date, mutations in 17 genes and 1 locus have been identified to cause FEVR, including Norrin (<italic>NDP</italic>) (<xref ref-type="bibr" rid="bib12">Chen et al., 1993</xref>), frizzled 4 (<italic>FZD4</italic>) (<xref ref-type="bibr" rid="bib66">Robitaille et al., 2002</xref>), low-density lipoprotein receptor-related protein 5 (<italic>LRP5</italic>) (<xref ref-type="bibr" rid="bib33">Gong et al., 2001</xref>; <xref ref-type="bibr" rid="bib40">Jiao et al., 2004</xref>), low-density lipoprotein receptor-related protein 6 (<italic>LRP6</italic>) (<xref ref-type="bibr" rid="bib49">Li et al., 2022</xref>), tetraspanin-12 (<italic>TSPAN12</italic>) (<xref ref-type="bibr" rid="bib41">Junge et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Nikopoulos et al., 2010</xref>), α-catenin (<italic>CTNNA1</italic>) (<xref ref-type="bibr" rid="bib87">Zhu et al., 2021</xref>), β-catenin (<italic>CTNNB1</italic>) (<xref ref-type="bibr" rid="bib60">Panagiotou et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Liu et al., 2024</xref>; <xref ref-type="bibr" rid="bib37">He et al., 2023</xref>), p120-catenin (<italic>CTNND1</italic>) (<xref ref-type="bibr" rid="bib81">Yang et al., 2022</xref>), zinc finger protein 408 (<italic>ZNF408</italic>) (<xref ref-type="bibr" rid="bib15">Collin et al., 2013</xref>), kinesin family member 11 (<italic>KIF11</italic>) (<xref ref-type="bibr" rid="bib67">Robitaille et al., 2014</xref>), atonal homolog 7 (<italic>ATOH7</italic>) (<xref ref-type="bibr" rid="bib43">Khan et al., 2012</xref>), exudative vitreoretinopathy 3 (<italic>EVR3</italic>) (<xref ref-type="bibr" rid="bib24">Downey et al., 2001</xref>), integrin-linked kinase (<italic>ILK</italic>) (<xref ref-type="bibr" rid="bib61">Park et al., 2019</xref>), jagged canonical Notch ligand 1 (<italic>JAG1</italic>) (<xref ref-type="bibr" rid="bib85">Zhang et al., 2020</xref>), discs large MAGUK scaffold protein 1 (<italic>DLG1</italic>) (<xref ref-type="bibr" rid="bib86">Zhang et al., 2021</xref>), transforming growth factor beta receptor 2 (<italic>TGFBR2</italic>) (<xref ref-type="bibr" rid="bib3">Asano et al., 2021</xref>), sorting nexin 31 (<italic>SNX31</italic>) (<xref ref-type="bibr" rid="bib79">Xu et al., 2023</xref>), and ER membrane protein complex subunit 1 (<italic>EMC1</italic>) (<xref ref-type="bibr" rid="bib50">Li et al., 2023</xref>). Nevertheless, these mutations can explain only approximately 50% of FEVR cases (<xref ref-type="bibr" rid="bib70">Salvo et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Kashani et al., 2014</xref>).</p><p>Calcyphosine-Like (<italic>CAPSL</italic>) is a protein-coding gene whose function remains elusive. In 2019, Julia Schreml pointed out that <italic>CAPSL</italic> is a promising candidate gene for multiple symmetric lipomatosis (MSL), a rare adipose tissue disorder of largely unknown etiology (<xref ref-type="bibr" rid="bib51">Lindner et al., 2019</xref>). Nevertheless, the specific pathogenic mechanism by which CAPSL triggers MSL remains unclear. The molecular mechanisms governing cellular processes and signaling cascades regulated by CAPSL have yet to be elucidated.</p><p><italic>MYC</italic> gene family is a group of genes most widely investigated and implicated in the formation, maintenance, and progression of several different cancer types, such as breast cancer, lymphoma, and prostatic cancer (<xref ref-type="bibr" rid="bib19">Dang, 2016</xref>; <xref ref-type="bibr" rid="bib6">Beaulieu et al., 2020</xref>; <xref ref-type="bibr" rid="bib10">Carroll et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Sander et al., 2012</xref>). MYC is a master regulator in MYC signaling, which participates in cell metabolism, proliferation, differentiation, and migration (<xref ref-type="bibr" rid="bib20">de Alboran et al., 2001</xref>). The important role of <italic>Myc</italic> in vascularization and angiogenesis during tumor development has already been reported in mouse models (<xref ref-type="bibr" rid="bib5">Baudino et al., 2002</xref>; <xref ref-type="bibr" rid="bib45">Knies-Bamforth et al., 2004</xref>). Vascular endothelial cell (EC)-specific knockout of <italic>Myc</italic> in mice led to impaired vascular expansion, thinned and poorly branched vascular, and reduced endothelial proliferation (<xref ref-type="bibr" rid="bib77">Wilhelm et al., 2016</xref>). Conversely, EC-specific <italic>Myc</italic> overexpression caused sustained vascular outgrowth, increased EC proliferation, and vessel density (<xref ref-type="bibr" rid="bib77">Wilhelm et al., 2016</xref>). These studies indicate that MYC is a regulating factor in coordinating EC behavior and vessel development.</p><p>In the current study, from a large cohort of FEVR patients, we identified a missense mutation and a stop-gain mutation in the <italic>CAPSL</italic> gene from four FEVR patients by whole-exome sequencing (WES) analysis. Furthermore, EC-specific <italic>Capsl</italic>-knockout mouse model exhibited FEVR-like retinal vascular defects, emphasizing the indispensable role of <italic>Capsl</italic> for the retinal vascular architecture. Knockdown of <italic>CAPSL</italic> led to compromised proliferation of stalk ECs and retarded migration of tip ECs by regulating the MYC signaling axis. Collectively, this study not only identifies <italic>CAPSL</italic> as a candidate gene for FEVR, but also presents that a compromised MYC signaling axis might contribute to FEVR.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>WES analysis revealed two <italic>CAPSL</italic> variants in FEVR patients</title><p>To evaluate the causative variants that account for FEVR, we applied WES on genomic DNA samples from 120 FEVR families without mutations in known FEVR genes. Sanger sequencing was further applied to validate the variants and genotype–phenotype co-segregation analysis. Thus, two novel candidate variants in the <italic>CAPSL</italic> gene (NM_144647) were identified in patients with FEVR, and the variants were predicted to be pathogenic by Mutation taster, Polyphen-2, and PROVEAN (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). In family 3036, a heterozygous c.88C&gt;T (p.R30X) variant was identified in an infant (age 0–5 years old) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). His father was a heterozygous carrier and manifested vascular defects in the retina, including peripheral neovascularization area and leakage by fundus fluorescein angiography, whereas the wild-type mother showed normal vision (<xref ref-type="fig" rid="fig1">Figure 1B, D</xref>). The affected amino acid is highly conserved among different species (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The proband (II:1) in the 3104 family has been diagnosed with FEVR and identified with a heterozygous variant c.247C&gt;T (p.L83F) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). His father has also been identified as a carrier of this heterozygous variant, manifested with FEVR symptoms, according to the medical records. Nevertheless, clinical examination data are presently unavailable.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>CAPSL</italic> point mutations in two families with familial exudative vitreoretinopathy (FEVR).</title><p>(<bold>A, B</bold>) FEVR pedigrees (patients are denoted with black symbols) and Sanger sequencing of two heterozygous mutations identified in two families. Black arrows indicate the proband of each family and red arrows indicate the changed nucleotides. (<bold>C</bold>) Alignment of amino sequences surrounding the <italic>CAPSL</italic> variants in different species and all mutated sites are highly conserved. Altered amino acid residues are highlighted in red. (<bold>D</bold>) Fundus fluorescein angiography (FFA) (left panel) and fundus photography (right panel) of a normal individual and FEVR-affected patient (I:1) in family 3036. Western blot (<bold>E, F</bold>) and quantitative real time polymerase chain reaction (RT-qPCR) analysis (<bold>G</bold>) of <italic>CAPSL</italic> expression of WT and mutant plasmids. An empty vector with GFP tag was used as a negative control. GFP was used as an internal reference. Error bars indicate the standard deviation (SD). **p &lt; 0.01, ****p &lt; 0.0001, ns: no significance, by Student’s <italic>t</italic> test (<italic>n</italic> = 3).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Subcellular localization of CAPSL variant proteins.</title><p>(<bold>A</bold>) Transfected 293T cells with wild-type CAPSL plasmid and variant plasmids were fixed and stained for CAPSL (green), GM130 (red, Golgi), and 4',6-diamidino-2-phenylindole (DAPI, blue, nucleus). Scale bar: 5 μm. (<bold>B</bold>) Transfected 293T cells with wild-type CAPSL plasmid and variant plasmids were stained for CAPSL (green) and Calnexin (red, endoplasmic reticulum). Scale bar: 5 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Bioinformatic prediction of an impact on splicing of the pathogenic variant c.88C&gt;T in <italic>CAPSL</italic>.</title><p>(<bold>A</bold>) MaxEntScan was used to investigate the impact of the variant on the formation of a cryptic donor splice site. Four different models were used: MAXENT: Maximum Entropy Model; MDD: Maximum Dependence Decomposition; MM: First-order Markov Model; WMM: Weight Matrix Model. (<bold>B</bold>) SpliceTool predicts an impact on splicing for the variant c.88C&gt;T.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig1-figsupp2-v1.tif"/></fig></fig-group><p>To determine the pathogenesis of <italic>CAPSL</italic> variants for FEVR, we first investigated the effect of variants on the expression of <italic>CAPSL</italic>. Wild-type and mutant coding sequences of <italic>CAPSL</italic> were introduced to the GFP-tagged pcDNA3.1 vector, and an IRES2 box was inserted to prevent the fusion expression of CAPSL and GFP. Immunoblot analysis of cells transfected with plasmids revealed that the CAPSL<italic>-</italic>R30X protein was undetectable, and the L83F variant resulted in a considerably reduced protein level (<xref ref-type="fig" rid="fig1">Figure 1E, F</xref>). Conversely, neither variant influenced the mRNA levels of <italic>CAPSL</italic> (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). CAPSL is localized in both the cytoplasm and the nucleus of cells (<ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org/">https://www.proteinatlas.org/</ext-link>), and we then further verified whether these variants have any impact on CAPSL localization. Immunocytochemistry analysis revealed that, consistent with immunoblot analysis, CAPSL-R30X protein was undetectable, and CAPSL-L83F mutant protein exhibited no significant change in localization (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The TGA stop codon can also have an effect on alternative splicing in certain scenarios, and bioinformatics predictions suggested that the impact of <italic>CAPSL</italic> 88C&gt;T variant on alternative splicing is minimal (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Thus, these variants may cause FEVR by reducing CAPSL protein abundance.</p></sec><sec id="s2-2"><title>Depletion of <italic>Capsl</italic> in vascular ECs caused FEVR-liked phenotypes</title><p>We generated an inducible EC-specific <italic>Capsl</italic>-knockout mouse model by breeding mice carrying a loxp-flanked allele of <italic>Capsl</italic> with tamoxifen-inducible <italic>Pdgfb-iCreER</italic> (<xref ref-type="bibr" rid="bib14">Claxton et al., 2008</xref>) transgenic animals to determine whether depletion of <italic>Capsl</italic> in mouse ECs could cause FEVR-like phenotypes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Sanger sequencing analysis confirmed that all experimental mice did not harbor confounding mutations such as <italic>rd1</italic> and <italic>rd8</italic> mutations (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). <italic>Capsl<sup>loxp/loxp</sup></italic>, <italic>Pdgfb-CreER</italic> mice (hereafter named iECKO), <italic>Capsl<sup>loxp/+</sup></italic>, <italic>Pdgfb-CreER</italic> mice (hereafter named iECKO/+), and their control littermates (<italic>Capsl<sup>loxp/loxp</sup></italic> and <italic>Pdgfb-CreER</italic>, hereafter named Ctrl) were induced by consecutive intraperitoneal injection of 50 μg tamoxifen per pup at postnatal day 1 (P1) to P3 before sacrifice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B, C</xref>). iECKO mice showed indistinguishable overall appearance compared to their Ctrl littermates. The efficiency of EC-specific deletion of <italic>Capsl</italic> was confirmed by real-time quantitative PCR (RT-qPCR) and western blot analysis of P35 mouse lung tissues. The results showed a pronounced reduction in CAPSL expression, at both mRNA and protein levels, in iECKO mice compared to Ctrl littermates (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>).</p><p>FEVR is a genetically heterogeneous eye disease characterized by incomplete vascularization of the peripheral retina in human patients. We initially assessed the vascular development in P5 iECKO/+ mice. The results exhibited no overt differences in vascular progression, vessel density, and vessel branchpoints between iECKO/+ mice and control littermates (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). This feature resembles the vascular development characteristics observed in other heterozygous mice carrying FEVR pathogenic genes, such as <italic>Lrp5</italic> (<xref ref-type="bibr" rid="bib78">Xia et al., 2008</xref>). To assess the role of <italic>CAPSL</italic> in the growth and patterning of retinal vasculature, we further employed retinal flat-mount analysis to visualize the retinal vessels at different postnatal ages in homozygous mice. As expected, the radial vascular growth, vessel density, and vascular branching were dramatically reduced in P5 iECKO retina relative to Ctrl mice (<xref ref-type="fig" rid="fig2">Figure 2A, D–F</xref>). The number of retinal vascular tip cells, which leads EC migration toward high vascular endothelial growth factor (VEGF) by extending filopodia at the angiogenic front (<xref ref-type="bibr" rid="bib64">Rattner et al., 2019</xref>), was considerably decreased and sparsely distributed in iECKO retinae, compared to that of control littermates (<xref ref-type="fig" rid="fig2">Figure 2B, C, G, H</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Endothelial cell (EC)-specific inactivation of <italic>Capsl</italic> impairs retina angiogenesis.</title><p>(<bold>A</bold>) Flat-mounted retinas obtained from P5 Ctrl and littermate iECKO mice were stained with Isolectin-B4 (IB4) to visualize blood vessel. Dashed circle mark the edge of the developing retina vessel in iECKO mice. Scale bar: 250 μm. (<bold>B</bold>) Low magnification images (top panels) and high magnification images (bottom panels) in boxed areas of IB4-stained angiogenic front of Ctrl and iECKO mice, respectively. Red cross mark tip cells at the angiogenic growth front. Scale bar: 100 μm (top panels), 25 μm (bottom panels). (<bold>C</bold>) High magnification images of filopodia-extending cells at the edge of retinal angiogenic growth front from Ctrl and iECKO mice. Red arrowheads indicate the sprouts at the angiogenic growth front. Scale bar: 50 μm. (<bold>D–H</bold>) Quantification of retinal vascular development parameters, including vascular progression, vessel density, branchpoints, number of tip cells, and number of filopodia. Error bars indicate the standard deviation (SD). **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 6).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Construction of endothelial cell (EC)-specific <italic>Capsl</italic>-knockout mice model and CAPSL knockdown human retinal microvascular endothelial cells (HRECs) model.</title><p>(<bold>A</bold>) Strategy to generate a conditional <italic>Capsl</italic> allele in which exon 2 are knockout specifically in ECs. (<bold>B</bold>) Diagram depicting the tamoxifen injection and experiment schedule for EC-specific deletion of <italic>Capsl</italic> in retinal vessels from P1 to P3 and their analyses timeline. (<bold>C</bold>) Polymerase Chain Reaction (PCR) of genomic DNA from Ctrl and iECKO pups. Recombination of the floxed <italic>Capsl</italic> allel occurs only in tamoxifen-injected animals that are Pdgfb-iCreER<italic>-</italic>positive. (<bold>D</bold>) Immunoblot and quantification of CAPSL-knockout efficiency at both protein and mRNA level. Error bars indicate the standard deviation (SD). **p &lt; 0.01, ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 3). (<bold>E</bold>) RT-PCR and RT-qPCR analysis of knockdown efficiency of lentivirus carrying sh<italic>CAPSL</italic>. Error bars indicate the SD. ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 3).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig2-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig2-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Experimental mice do not carry confounding <italic>rd1</italic> and <italic>rd8</italic> mutations.</title><p>(<bold>A</bold>) Sanger sequencing was performed to verify the <italic>Pde6b</italic> c.1041T&gt;C in rd1 mice and experimental mice. (<bold>B</bold>) Sanger sequencing was performed to verify the <italic>Crb1</italic> c.3481C deletion in rd8 mice and experimental mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title><italic>Capsl</italic> heterozygous mice exhibited no significant defect in angiogenesis.</title><p>(<bold>A</bold>) Flat-mounted retinas obtained from P5 iECKO/+, iECKO, and littermate Ctrl mice were stained with Isolectin-B4 (IB4) to visualize blood vessel. Dashed circle mark the edge of the developing retina vessel in Ctrl mice. Scale bar: 250 μm. (<bold>B–D</bold>) Quantification of retinal vascular development parameters, including vascular progression, vessel density, and branchpoints. Error bars indicate the standard deviation (SD). ***p &lt; 0.001, ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 4).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig2-figsupp3-v1.tif"/></fig></fig-group><p>The onset of mouse retinal vascular development occurs postnatally at P0, coinciding with the regression of the hyaloid vasculature (<xref ref-type="bibr" rid="bib69">Saint-Geniez and D’amore, 2004</xref>; <xref ref-type="bibr" rid="bib39">Ito and Yoshioka, 1999</xref>). Similar to the previously reported hyaloid phenotypes observed in the FEVR-associated mouse models (<xref ref-type="bibr" rid="bib41">Junge et al., 2009</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>), the hyaloid vasculature in iECKO at P10 displayed delayed regression in comparison to the Ctrl littermates (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Following the expansion of the superficial vessel plexus at around P8, retinal vessels extend perpendicularly into the deep retina, forming secondary and deep third capillary layers (<xref ref-type="bibr" rid="bib30">Fruttiger, 2007</xref>). To investigate whether the depletion of <italic>Capsl</italic> hinders deep capillary vascular development, we conducted immunostaining on P10 retinal sections. The results revealed a delayed development of deep retinal vessels in iECKO mouse retinae compared to that of Ctrl (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). In addition, immunostaining of P14 flat-mount retina confirmed an incomplete architecture of the deep vascular layer in iECKO mouse (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). By P21, EC growth was closely resembling control retinas in iECKO mice when angiogenesis almost complete (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Loss of <italic>Capsl</italic> results in delayed hyaloid regression and deep retinal blood vessel growth.</title><p>(<bold>A</bold>) Hyaloid vessels stained with DAPI in the eyes of Ctrl and iECKO mice at P10. Scale bar: 250 μm. (<bold>B</bold>) Retina sections from P10 Ctrl and iECKO mice were co-stained with Isolectin-B4 (IB4) (greed) and DAPI (blue). Scale bar: 100 μm. (<bold>C</bold>) Flat-mounted retains stained with IB4 at P14 Ctrl and iECKO mice. Optical sections of z-stacked confocal images were divided to represent the nerve fiber layer (NFL), inner plexiform layer (IPL), and outer plexiform layer (OPL). Dashed lines mark the edge of the developing retina. Scale bar: 100 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Capsl deletion does not affect vessel maturation.</title><p>Flat-mounted retinas stained with Isolectin-B4 (IB4) at P21 Ctrl and iECKO. Optical sections of z-stacked confocal images were divided to represent the nerve fiber layer (NFL), inner plexiform layer (IPL), and outer plexiform layer (OPL). Scale bar: 250 μm (left panel) and 100 μm (right panel).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>CAPSL controls vascular proliferation and migration</title><p>The development of retinal vasculature is a complex process encompassing not only the coordinated behavior of ECs but also the intricate interactions among different cell types and cytokines within the retina (<xref ref-type="bibr" rid="bib73">Selvam et al., 2018</xref>). Astrocytes form a mesh as a template prior to vascular growth and guide angiogenic expansion by secreting gradient distributed VEGFA (<xref ref-type="bibr" rid="bib23">Dorrell et al., 2002</xref>; <xref ref-type="bibr" rid="bib32">Gerhardt et al., 2003</xref>; <xref ref-type="bibr" rid="bib74">Stenzel et al., 2011</xref>). Abnormal activation of astrocytes and subsequent inflammatory responses have been observed in multiple FEVR mouse models (<xref ref-type="bibr" rid="bib41">Junge et al., 2009</xref>; <xref ref-type="bibr" rid="bib87">Zhu et al., 2021</xref>; <xref ref-type="bibr" rid="bib30">Fruttiger, 2007</xref>; <xref ref-type="bibr" rid="bib56">Luhmann et al., 2005</xref>). To explore whether the gradient and expression level of VEGFA were affected by the depletion of <italic>Capsl</italic>, we conducted immunostaining of VEGFA on the retina. However, the results showed no alteration of VEGFA (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Meanwhile, the activation state and the pattern of the vascular template for EC outgrowth formed by astrocytes remained normal, indicated by glial fibrillary acidic protein (GFAP) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Pericyte recruitment is necessary for vessel stability and maturation (<xref ref-type="bibr" rid="bib38">Hellström et al., 2001</xref>). The immunostaining of Desmin or NG2 staining exhibited no difference between Ctrl and iECKO mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). To assess the integrity of the retinal vascular barrier, we performed the intraperitoneal injection of 5- (and-6)-tetramethylrhodamine biocytin (biocytin-TMR, 869 Da), a small-molecular-weight fluorescent tracerm (<xref ref-type="bibr" rid="bib46">Knowland et al., 2014</xref>). The results showed no notable leakage in the iECKO retina, suggesting the intact blood barrier despite the depletion of ECs-<italic>Capsl</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). The extracellular matrix (ECM) coordinates the behavior of ECs by regulating cell–cell communication processes (<xref ref-type="bibr" rid="bib52">Liu and Senger, 2004</xref>). The deficiency and abnormal accumulation of ECM can both disrupt the adhesion, proliferation, and migration of the ECs, leading to defects in blood vessel architecture (<xref ref-type="bibr" rid="bib31">Fujiwara et al., 2004</xref>; <xref ref-type="bibr" rid="bib27">Fischer et al., 2009</xref>; <xref ref-type="bibr" rid="bib72">Santos-Oliveira et al., 2015</xref>). We thus analyzed the ECM accumulation using fibronectin 1, and the result showed normal deposition of ECM (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>). In conclusion, EC-specific knockout of <italic>Capsl</italic> may mainly lead to defects in retinal vascular ECs rather than other vascular-associated cells.</p><p>Considering the compromised vascular progression and decreased vessel density in iECKO mouse retinae, we first performed the EdU assay on retina flat mounts co-stained with ETS transcription factor ERG (endothelial cell nuclear marker) to assess the proliferation of ECs. The results showed a strongly reduced proliferation of <italic>Capsl</italic>-defective ECs compared to that of Ctrl (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). As previously reported, the regressed retinal vessels exhibited sleeve-like positivity for basement matrix component Collagen IV and negativity for Isolectin IB4 (<xref ref-type="bibr" rid="bib7">Birdsey et al., 2015</xref>). To compare the vascular regression between iECKO and Ctrl retinae, we conducted co-staining of the Collagen IV and IB4. The results revealed that depletion of <italic>Capsl</italic> leads to an increased vascular regression, evidenced by a significant increase in Collagen IV basal membrane sleeves lacking IB4 both in the capillary plexus and angiogenic front (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Deletion of <italic>Capsl</italic> impairs endothelial cell (EC) proliferation and migration.</title><p>(<bold>A</bold>) Retina EC proliferation of Ctrl and iECKO mice at the vitreal surface was measured with EdU and ERG labeling at P5. Images captured at higher magnification are shown at right. Dashed lines mark the edge of the developing retina, and dashed circles represent both EdU+ and ERG+ cells. EC proliferation ability was measured by the ration of EdU+ and ERG+ cells per vascular area. Scale bar: 200 and 50 μm (enlarged insets). Error bars indicate the standard deviation (SD). ***p &lt; 0.001, by Student’s <italic>t</italic> test (<italic>n</italic> = 6). (<bold>B</bold>) Representative images of retinal vessels at the periphery plexus and inner plexus of Ctrl and iECKO mice at P5 co-stained with Isolectin-B4 (IB4) (green) and Collagen IV (red). Arrowhead point to empty Collagen IV sleeves. And quantification of ratio of Collagen IV-positive vessel segments to IB4 labeling-negative vessel segments. Scale bar: 50 μm. Error bars indicate the standard deviation (SD). ***p &lt; 0.001, ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 6). (<bold>C</bold>) Magnified images of IB4+ vessels and ERG+ nuclei of ECs at angiogenic front of Ctrl and iECKO mice at P5. Quantification of tip cell nuclear ellipticity at the angiogenic growth front. Scale bar: 50 μm. Error bars indicate the standard deviation (SD). ***p &lt; 0.001, by Student’s <italic>t</italic> test (<italic>n</italic> = 14).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Normal state of other cell types and extracellular matrix (ECM) deposition in <italic>Capsl</italic>-knockout mice retina.</title><p>(<bold>A</bold>) Co-staining of VEGFA (red) and Isolectin-B4 (IB4) (green) at angiogenic front and remodeling plexus in P5 retinas of Ctrl and iECKO mice. Scale bar: 50 μm. (<bold>B</bold>) Co-staining of Collagen IV (red) and IB4 (green) in P5 retinas of Ctrl and iECKO mice. Scale bar: 50 μm. (<bold>C</bold>) Maximum intensity projections and quantification of pericyte coverage of the superficial vascular plexus in P5 retinas of Ctrl and iECKO mice stained with Desmin/NG2 (red) and IB4 (green). Scale bar: 50 μm. Error bars indicate the standard deviation (SD). ns: no significance, by Student’s <italic>t</italic> test (<italic>n</italic> = 6). (<bold>D</bold>) Representative confocal images of biocytin-TMR (red) and IB4 (green) in the retinal flat mounts from P5 Ctrl and iECKO mice. Scale bar: 50 μm. (<bold>E</bold>) Immunofluorescence staining and quantitative analysis of FN-1 (red) stained ECM deposition in retinas form P5 Ctrl and iECKO mice. Scale bar: 50 μm. Error bars indicate the standard deviation (SD). ns: no significance, by Student’s <italic>t</italic> test (<italic>n</italic> = 6).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Additionally, considering the pivotal role of tip cells in the direction of vascular development, we then asked whether depletion of <italic>Capsl</italic> impairs the polarity of tip cells by analyzing the morphology of cell nuclei at the angiogenic front. This analysis was based on the observation that the nuclei of actively migrating tip cells are elliptical and exhibit increased sphericity (decreased ellipticity) in static tip cells (<xref ref-type="bibr" rid="bib16">Coxam et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Kim et al., 2019</xref>). In Ctrl mice retinae, the nuclei of tip ECs were predominantly elliptical, pointing toward the avascular area (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Conversely, in the retinae of iECKO mice, the nuclei of tip ECs appeared more spherical and did not orient toward the avascular area (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). These findings suggest that CAPSL is critical for EC proliferation, vascular regression, and cell polarity.</p></sec><sec id="s2-4"><title>Endothelial CAPSL is required for cell polarity and filopodia/lamellipodia formation</title><p>To investigate the functional mechanism and signaling cascade by which CAPSL regulates EC behaviors, we performed in vitro experiments on primary human retinal microvascular endothelial cells (HRECs). Stable <italic>CAPSL</italic> knockdown HRECs were generated using the lentivirus-mediated shRNA system. RT-qPCR analysis showed that the mRNA level of <italic>CAPSL</italic> was significantly decreased (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). In line with the overall reduced vascular coverage in iECKO mice retina, <italic>CAPSL</italic>-knockdown HRECs (sh<italic>CAPSL</italic>-ECs) exhibited considerably impaired tube formation in vitro (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). EdU labeling also revealed decreased cell proliferation of sh<italic>CAPSL</italic>-ECs compared to that of shCtrl-ECs (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). We further conducted flow cytometry to determine whether cell cycle arrest occurred upon depletion of <italic>CAPSL</italic> in HRECs. The redistribution of cell cycle phases indicated that the cell cycle was arrested during the G0/G1 phase in the sh<italic>CAPSL</italic>-ECs (<xref ref-type="fig" rid="fig5">Figure 5C, D</xref>). To further investigate the role of CAPSL in EC migration, we performed the scratch-wound assay in confluent sh<italic>CAPSL</italic>-ECs and shCtrl-ECs, as previously reported (<xref ref-type="bibr" rid="bib44">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib11">Carvalho et al., 2019</xref>). Nine hours after scratching, ECs were co-stained with GM130 and phalloidin to visualize the Golgi apparatus and the cytoskeleton. The results indicated that the nuclei of sh<italic>CAPSL</italic>-ECs were more spherical than those of shCtrl-ECs (<xref ref-type="fig" rid="fig5">Figure 5E, F</xref>). Given that the axial polarity can reflect the direction and migration of ECs (<xref ref-type="bibr" rid="bib29">Franco et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Kwon et al., 2016</xref>), we further measured the cell polarity (nucleus-to-Golgi polarity axis) of ECs at the wound edge (<xref ref-type="bibr" rid="bib44">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib11">Carvalho et al., 2019</xref>). As a result, the Golgi apparatus of shCtrl-ECs was predominantly positioned around the wound edge, while that of sh<italic>CAPSL</italic>-ECs showed more random positioning (<xref ref-type="bibr" rid="bib63">Potente et al., 2011</xref>; <xref ref-type="fig" rid="fig5">Figure 5H</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Depletion of <italic>CAPSL</italic> in human retinal microvascular endothelial cells (HRECs) compromises in vitro endothelial cell (EC) proliferation and migration.</title><p>(<bold>A</bold>) Representative images of in vitro tube formation after transfection of HRECs with shRNA. Scale bar: 200 μm. Error bars indicate the standard deviation (SD). ***p &lt; 0.001, ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 6). (<bold>B</bold>) Incorporation of EdU in shRNA transfected HRECs. Representative confocal images and quantification of proliferating HRECs both in number per field and proportion of EdU-positive cells. Scale bar: 50 μm. Error bars indicate the standard deviation (SD). ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 10). (<bold>C, D</bold>) Cell cycle analysis of shCtrl-ECs and sh<italic>CAPSL</italic>-ECs by flow cytometry. Error bars indicate the standard deviation (SD). ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 4). (<bold>E</bold>) Representative images of phalloidin actin cytoskeleton (green) and GM130 (red) showing polarity angles of shCtrl-ECs and sh<italic>CAPSL</italic>-ECs at the edge of scratch wound. The arrow points toward the wound. Colored arrowheads represent different migration state. Scale bar: 200 μm (left panel), 50 μm (right panel). (<bold>F</bold>) Quantification of nuclear ellipticity of HRECs at the margin of wound scratch. Error bars indicate the standard deviation (SD). ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 14). (<bold>G</bold>) Schematic pictures showing the define of polarity axis of each cell. Polarity axis was measured with the angle (<italic>α</italic>) between the scratch edge and the vector drawn from the center of nucleus to the center of the Golgi apparatus. (<bold>H</bold>) Polar plots showing Golgi apparatus polarization. The bold lines represent 120° region centered on the vector, which is perpendicular to the wound scratch. The dots represent the angle (<italic>α</italic>) of each cell and the numbers indicate the frequency of dots within the 120° region of the bold line of shCtrl-ECs (<italic>n</italic> = 243) and sh<italic>CAPSL</italic>-ECs (<italic>n</italic> = 244). (<bold>I</bold>) Images of phalloidin-stained actin cytoskeleton and comparisons of indicated parameters in shCtrl-ECs and sh<italic>CAPSL</italic>-ECs at the edge of scratch wound. The dashed boxed region is shown at higher magnification at the bottom panel. Scale bar: 50 μm (top panels), 25 μm (bottom panels). Error bars indicate the standard deviation (SD). **p &lt; 0.01, by Student’s <italic>t</italic> test (<italic>n</italic> = 6). (<bold>J</bold>) Representative images of wound scratch assay at 0, 12, and 16 hr after wound was made. And the quantification of covered area at different time point. The dashed line indicates the gap of the wound after wound scratch at different time point. Scale bar: 200 μm. Error bars indicate the standard deviation (SD). ****p &lt; 0.0001, ns：no significance, by Student’s <italic>t</italic> test (<italic>n</italic> = 6). (<bold>K</bold>) Immunoblot and quantification analysis of expression of small GTPase proteins and a key regulator of contractile force MYL9 in shCtrl-ECs and sh<italic>CAPSL</italic>-ECs. Error bars indicate the standard deviation (SD). *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, by Student’s <italic>t</italic> test (<italic>n</italic> = 3).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig5-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig5-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig5-v1.tif"/></fig><p>At the angiogenic front, the dynamic behaviors of tip cells largely rely on the rearrangement and organization of the actin cytoskeleton (<xref ref-type="bibr" rid="bib22">De Smet et al., 2009</xref>). Tip cells extend actin-driven filopodia and lamellipodia to probe chemotactic guidance cues, providing direction and migration for the developing vascular network (<xref ref-type="bibr" rid="bib47">Kurz et al., 1996</xref>; <xref ref-type="bibr" rid="bib57">Marin‐Padilla, 1985</xref>; <xref ref-type="bibr" rid="bib68">Ruhrberg et al., 2002</xref>). Notably, sh<italic>CAPSL</italic>-ECs exhibited fewer filopodia, smaller lamellipodia, and significantly impaired wound closure compared to shCtrl-ECs at the wound scratch edge (<xref ref-type="fig" rid="fig5">Figure 5I</xref>). Also, as expected, sh<italic>CAPSL</italic>-ECs exhibited significantly impaired wound closure at the same time point after scratching relative to shCtrl-ECs (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). Small Rho GTPases, including CDC42 and Rac, are essential for lamellipodial extension and cell migration (<xref ref-type="bibr" rid="bib28">Fraccaroli et al., 2015</xref>; <xref ref-type="bibr" rid="bib36">Hall, 2005</xref>). Western blot analysis uncovered markedly attenuated expression of CDC42, RHOA, and Rac1 (<xref ref-type="fig" rid="fig5">Figure 5K</xref>). Moreover, both MYL9 and phosphorylated MYL9 at Ser19, which are crucial regulators of contractile force, were also drastically reduced in sh<italic>CAPSL</italic>-ECs compared to those of shCtrl-ECs (<xref ref-type="fig" rid="fig5">Figure 5K</xref>). These results indicated that CAPSL regulates EC polarity, filipodia/lamellipodia formation, and migration by modulating the actomyosin cytoskeleton.</p></sec><sec id="s2-5"><title>CAPSL regulates EC proliferation through the MYC signaling axis</title><p>Given the fact that FEVR is predominantly characterized by the compromised Norrin/β-catenin signaling pathway as its main causative factor (<xref ref-type="bibr" rid="bib12">Chen et al., 1993</xref>; <xref ref-type="bibr" rid="bib41">Junge et al., 2009</xref>; <xref ref-type="bibr" rid="bib87">Zhu et al., 2021</xref>; <xref ref-type="bibr" rid="bib60">Panagiotou et al., 2017</xref>), we first asked whether loss of CAPSL function causes FEVR through Norrin/β-catenin signaling. TopFlash reporter gene system was used to determine the activity of the Norrin/β-catenin signaling pathway. Knocking down <italic>CAPSL</italic> expression in human embryonic kidney 293 (HEK293) SuperTopFlash (STF) cells led to similar luciferase activity, compared to cells transfected with shCtrl (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Furthermore, transfection of <italic>shRNA</italic>-resistant CAPSL plasmid (WT, R30X, or L83F) in <italic>CAPSL</italic>-knockdown 293STF cells resulted in no significant difference in luciferase activity (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). These results indicated that <italic>CAPSL</italic> was not a major player in Norrin/β-catenin signaling to regulate retinal vascular development.</p><p>We next performed unbiased transcriptomic and proteomic analyses on the control and <italic>CAPSL</italic>-knockdown HRECs to explore the underlying mechanism by which <italic>CAPSL</italic> regulates EC proliferation and migration. RNA sequencing (RNA-seq) identified 1961 up-regulated genes and 2205 down-regulated genes in sh<italic>CAPSL</italic>-ECs compared to shCtrl-ECs (logFC &gt;0.58, p-value &lt;0.05), 1342 up-regulated genes and 1218 down-regulated genes in ECs overexpressing <italic>CAPSL</italic> (LentiOE-ECs) compared to Ctrl-ECs (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Gene set enrichment analysis (GSEA) on transcriptomic data showed multiple down-regulated signaling axes upon the depletion of <italic>CAPSL</italic>, including E2F targets (NES = −3.2944438, p-value = 0), G2/M checkpoints (NES = −3.2851038, p-value = 0), MYC targets (NES = −2.8795638, p-value = 0), and mitotic spindle (NES = −2.646523, p-value = 0) (<xref ref-type="fig" rid="fig6">Figure 6B, C</xref>). In line with this, overexpression of CAPSL in HRECs also caused a significant increase in E2F targets (NES = 2.7765026, p-value = 0), G2/M checkpoints (NES = 2.6528199, p-value = 0), and MYC targets (NES = 2.6528199, p-value = 0) (<xref ref-type="fig" rid="fig6">Figure 6D, E</xref>). Meanwhile, proteomic profiling showed similar expression patterns with that of transcriptomic profiling upon knockdown or overexpression of <italic>CAPSL</italic> (<xref ref-type="fig" rid="fig6">Figure 6F–I</xref>). Furthermore, we applied correlation analysis on the transcriptomic and proteomic data, which divided the genes into nine quadrants (<xref ref-type="fig" rid="fig6">Figure 6J</xref>). GSEA analysis was performed on genes in the third and seventh quadrants, which were regulated at the transcriptional level (<xref ref-type="fig" rid="fig6">Figure 6K</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Interestingly, the down-regulated signaling pathways are highly consistent with those observed in GSEA analysis of both transcriptomic and proteomic analyses (<xref ref-type="fig" rid="fig6">Figure 6K</xref>). Given that the MYC was an established driver of cell growth and migration (<xref ref-type="bibr" rid="bib55">Lourenco et al., 2021</xref>), and that the genes in the MYC signaling were down-regulated upon <italic>CAPSL</italic> depletion (<xref ref-type="fig" rid="fig6">Figure 6L</xref>), we speculated that CAPSL might play a pivotal role in MYC signaling in HRECs. RT-qPCR analysis was further performed to validate the downregulation fo MYC target genes in the lung tissue of Ctrl and iECKO mice (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>CAPSL</italic> suppresses MYC signaling axis.</title><p>(<bold>A</bold>) Differential gene expression information of sh<italic>CAPSL</italic>-ECs versus shCtrl-ECs group and LentiOE-ECs versus shCtrl-ECs group. (<bold>B–E</bold>) Gene set enrichment analysis (GSEA) on the RNA sequencing data of human retinal microvascular endothelial cells (HRECs). Top 10 ranked up- or down-regulated signaling axis was listed (<bold>B</bold>) and top 4 down-regulated gene sets were listed (<bold>C</bold>) in comparison of shCtrl-ECs versus sh<italic>CAPSL</italic>-ECs. Top 10 ranked up- or down-regulated signaling axis was listed (<bold>D</bold>) and top 4 up-regulated gene sets were listed (<bold>E</bold>) in comparison of LentiOE-ECs versus shCtrl-ECs. (<bold>F–I</bold>) GSEA on the proteomic profiling data of HRECs. Top 10 ranked up- or down-regulated signaling axis was listed (<bold>F</bold>) and top 4 down-regulated gene sets were listed (<bold>G</bold>) in comparison of shCtrl-ECs versus sh<italic>CAPSL</italic>-ECs. Top 10 ranked up- or down-regulated signaling axis was listed (<bold>H</bold>) and top 4 up-regulated gene sets were listed (<bold>I</bold>) in comparison of LentiOE-ECs versus shCtrl-ECs. (<bold>J</bold>) Correlated RNAs and proteins enriched in nine quadrants of shCtrl-ECs versus sh<italic>CAPSL</italic>-ECs. (<bold>K</bold>) GSEA on the genes/proteins in quadrants 3 and 7, and top 5 ranked up- or down-regulated signaling axis was listed. (<bold>L</bold>) Clustered heatmap of the expression fold changes of several MYC signature genes of in both RNA profiling and proteomic profiling of shCtrl-ECs and sh<italic>CAPSL</italic>-ECs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>CAPSL is not involve in Norrin/β-catenin signaling pathway.</title><p>(<bold>A</bold>) Results of luciferase reporter assay of shCtrl-293STF cells and sh<italic>CAPSL</italic>-293STF cells. Error bars indicate the standard deviation (SD). ns: no significance, by Student’s <italic>t</italic> test (<italic>n</italic> = 6). (<bold>B</bold>) Results of luciferase reporter assay of sh<italic>CAPSL</italic>-293STF cells were transfected with plasmids containing <italic>CAPSL</italic> (WT, R30X, or L83F) or empty vector. Error bars indicate the standard deviation (SD). ns: no significance, by Student’s <italic>t</italic> test (<italic>n</italic> = 5).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title><italic>Capsl</italic> depletion resulted in downregulation of MYC targets.</title><p>(<bold>A</bold>) MYC expression level of P40 Ctrl and iECKO mice lung tissue was quantified by western blot and RT-qPCR. Error bars indicate the standard deviation (SD). **p &lt; 0.01, ns: no significance by Student’s <italic>t</italic> test (<italic>n</italic> = 3). (<bold>B</bold>) Relative mRNA expression of MYC targets of P35 Ctrl and iECKO mice lung tissue. Error bars indicate the standard deviation (SD). ***p &lt; 0.001, ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 4).</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig6-figsupp2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s2sdata2"><label>Figure 6—figure supplement 2—source data 2.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig6-figsupp2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig6-figsupp2-v1.tif"/></fig></fig-group><p>We next incorporated an analysis of transcriptome profiling of human umbilical vein endothelial cells (HUVECs) infected with lentiviruses encoding control- or <italic>MYC</italic>-targeting genomic RNAs (gRNAs; GSE161815) (<xref ref-type="bibr" rid="bib2">Andrade et al., 2021</xref>). Intriguingly, GSEA analysis revealed that ablation of cMYC in HUVECs led to compromised E2F targets, MYC targets, and G2/M checkpoint signaling activity (<xref ref-type="fig" rid="fig7">Figure 7A, B</xref>), largely consistent with those observed in the absence of <italic>CAPSL</italic>. This also suggests that cMYC might play a role in the upstream regulation of E2F targets and G2/M checkpoint signaling. Venn diagram analysis of down-regulated genes (LogFC &lt;−0.585, p &lt; 0.05) in <italic>CAPSL</italic>-depleted HRECs and <italic>MYC</italic>-depleted HUVECs revealed a large proportion of shared genes, indicative of similar transcriptional regulatory patterns between CAPSL and MYC (<xref ref-type="fig" rid="fig7">Figure 7C</xref> and <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Additionally, these genes are predominently enriched in the MYC targets signaling (<xref ref-type="fig" rid="fig7">Figure 7D–F</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Loss of <italic>CAPSL</italic> led to similar transcriptional regulatory patterns to the loss of <italic>MYC</italic> in human umbilical vein endothelial cells (HUVECs).</title><p>(<bold>A, B</bold>) Gene set enrichment analysis (GSEA) on the RNA sequencing data in comparison of shCtrl-HUVECs versus sh<italic>MYC</italic>-HUVECs. Top 10 ranked up- or down-regulated signaling axis was listed (<bold>A</bold>) and top 4 down-regulated gene sets were listed (<bold>B</bold>). (<bold>C</bold>) Venn diagram analysis of down-regulated genes in <italic>CAPSL</italic>-depleted human retinal microvascular endothelial cells (HRECs) and <italic>cMYC</italic>-depleted HUVECs. (<bold>D, E</bold>) GSEA on the shared down-regulated genes in <italic>CAPSL</italic>-depleted HRECs and <italic>MYC</italic>-depleted HUVECs. (<bold>F</bold>) Heatmap of MYC signature genes of shared genes based on Venn analysis. (<bold>G</bold>) MYC expression level in shCtrl-ECs and sh<italic>CAPSL</italic>-ECs was quantified by western blot and RT-qPCR. Error bars indicate the standard deviation (SD). ****p &lt; 0.0001, ns: no significance by Student’s <italic>t</italic> test (<italic>n</italic> = 3). (<bold>H</bold>) Western blot analysis of expression of MYC targets. (<bold>I</bold>) Quantification analysis of MYC targets. Error bars indicate the standard deviation (SD). *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, by Student’s <italic>t</italic> test (<italic>n</italic> = 3).</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig7">Figure 7.</xref></title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig7-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-96907-fig7-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96907-fig7-v1.tif"/></fig><p>We, therefore, asked whether CAPSL regulates MYC expression. Notably, the depletion of <italic>CAPSL</italic> significantly decreased the protein level of MYC, rather than the mRNA level in HRECs (<xref ref-type="fig" rid="fig7">Figure 7G</xref>). Subsequently, western blot analysis revealed that expression levels of MYC target genes, such as MCM family, E2F1, CyclinD family, and PCNA, were decreased in the absence of <italic>CAPSL</italic> in HRECs (<xref ref-type="fig" rid="fig7">Figure 7H, I</xref>). Taken together, these findings suggest MYC as a potential functional regulator downstream of CAPSL.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Over the last decades, major progress has been made in understanding the molecular mechanisms underlying FEVR, and 17 FEVR-causing genes have been identified (<xref ref-type="bibr" rid="bib12">Chen et al., 1993</xref>; <xref ref-type="bibr" rid="bib66">Robitaille et al., 2002</xref>; <xref ref-type="bibr" rid="bib33">Gong et al., 2001</xref>; <xref ref-type="bibr" rid="bib40">Jiao et al., 2004</xref>; <xref ref-type="bibr" rid="bib49">Li et al., 2022</xref>; <xref ref-type="bibr" rid="bib41">Junge et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Nikopoulos et al., 2010</xref>; <xref ref-type="bibr" rid="bib87">Zhu et al., 2021</xref>; <xref ref-type="bibr" rid="bib60">Panagiotou et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Liu et al., 2024</xref>; <xref ref-type="bibr" rid="bib37">He et al., 2023</xref>; <xref ref-type="bibr" rid="bib81">Yang et al., 2022</xref>; <xref ref-type="bibr" rid="bib15">Collin et al., 2013</xref>; <xref ref-type="bibr" rid="bib67">Robitaille et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Khan et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Downey et al., 2001</xref>; <xref ref-type="bibr" rid="bib61">Park et al., 2019</xref>; <xref ref-type="bibr" rid="bib85">Zhang et al., 2020</xref>; <xref ref-type="bibr" rid="bib86">Zhang et al., 2021</xref>; <xref ref-type="bibr" rid="bib3">Asano et al., 2021</xref>; <xref ref-type="bibr" rid="bib79">Xu et al., 2023</xref>; <xref ref-type="bibr" rid="bib50">Li et al., 2023</xref>). However, the pathogenic genes and mechanisms underlying approximately 50% of clinical cases remain elusive (<xref ref-type="bibr" rid="bib37">He et al., 2023</xref>; <xref ref-type="bibr" rid="bib81">Yang et al., 2022</xref>). In this study, we report a new FEVR candidate gene <italic>CAPSL</italic> and uncover the pivotal roles of CAPSL in retina vascular development. The EC-specific <italic>Capsl</italic>-knockout mouse model exhibited FEVR phenotypes, including delayed vascular progression, retarded hyaloid vessel regression, and decreased vessel density. Deficiency of CAPSL in ECs resulted in compromised cell proliferation and defective EC migration, providing insights into the regulatory roles of CAPSL in retina vascularization (<xref ref-type="fig" rid="fig2">Figures 2</xref>—<xref ref-type="fig" rid="fig5">5</xref>).</p><p>During retinal development, angiogenesis comprises various processes such as EC specification, adhesion, proliferation, migration, and pruning (<xref ref-type="bibr" rid="bib30">Fruttiger, 2007</xref>). The regulation of angiogenesis entails the control of EC behaviors and the interactions between ECs, ECM, and other types of retinal cells (<xref ref-type="bibr" rid="bib29">Franco et al., 2015</xref>). In this study, we observed impaired radial expansion and vertical invasion, as well as the increased pruning of the retinal vascular ECs upon inactivating endothelial <italic>Capsl</italic> (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>). However, neither the expression level nor the gradience of VEGFA was disturbed in iECKO mice, which could be attributed to the intact blood barrier in the iECKO retina (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). In addition, the loss of <italic>Capsl</italic> resulted in the presence of more spherical tip cell nuclei, which were directed more randomly to the avascular area (<xref ref-type="fig" rid="fig4">Figure 4</xref>). These results provide evidence that CAPSL acts as a novel regulator for collective EC behavior.</p><p>In vitro functional studies demonstrated that depletion of <italic>CAPSL</italic> impaired tube formation, EC proliferation ability, and EC polarity (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Moreover, the formation of filopodia and lamellipodia is also disturbed by the depletion of <italic>CAPSL</italic> (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Using the unbiased transcriptomic and proteomic sequencing, bioinformatic analysis, and western blot assay, we demonstrated that the defects in <italic>CAPSL</italic> affect EC function by down-regulating the MYC signaling cascade (<xref ref-type="fig" rid="fig6">Figures 6</xref> and <xref ref-type="fig" rid="fig7">7</xref>). MYC has been shown to be a critical mediator of anabolic metabolism, cell growth, and migration (<xref ref-type="bibr" rid="bib18">Dang, 2013</xref>; <xref ref-type="bibr" rid="bib1">Adhikary and Eilers, 2005</xref>). Aberrant upregulation of the MYC signaling pathway is frequently observed in many types of cancers (<xref ref-type="bibr" rid="bib17">Dang, 2012</xref>; <xref ref-type="bibr" rid="bib75">Stine et al., 2015</xref>). Interestingly, the phenotypes of retinal vessels in iECKO mice resemble the vascular defects in <italic>Myc<sup>iEC-KO</sup></italic> mice, exhibiting FEVR-like phenotypes, such as impaired vascular progression, decreased branch points, and reduced EC proliferation (<xref ref-type="bibr" rid="bib20">de Alboran et al., 2001</xref>; <xref ref-type="bibr" rid="bib77">Wilhelm et al., 2016</xref>).</p><p>The Norrin/β-catenin signaling pathway is a subset of Wnt signaling pathway that is specifically activated during vascular development of the central nervous system (<xref ref-type="bibr" rid="bib37">He et al., 2023</xref>; <xref ref-type="bibr" rid="bib58">Martowicz et al., 2019</xref>). Although several signaling pathways have been implicated in the pathogenesis of FEVR, variants in crucial components of Norrin/β-catenin signaling account for most of the FEVR cases (<xref ref-type="bibr" rid="bib41">Junge et al., 2009</xref>; <xref ref-type="bibr" rid="bib87">Zhu et al., 2021</xref>; <xref ref-type="bibr" rid="bib60">Panagiotou et al., 2017</xref>). It is worth mentioning that MYC is widely recognized as a downstream target of Wnt signaling, which is transcriptionally regulated during Wnt activation (<xref ref-type="bibr" rid="bib35">Green et al., 2024</xref>; <xref ref-type="bibr" rid="bib65">Rennoll and Yochum, 2015</xref>; <xref ref-type="bibr" rid="bib8">Cairo et al., 2012</xref>). However, to our knowledge, there is a lack of literature reporting on the correlation between the MYC signaling pathway and FEVR. Interestingly, here we proved that the absence of CAPSL leads to a decrease in MYC protein level, which down-regulates MYC signaling without affecting Norrin/β-catenin signaling (<xref ref-type="fig" rid="fig7">Figure 7</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Consequently, we propose MYC as a potential therapeutic target for FEVR, a hypothesis that warrants substantiation through subsequent investigations.</p><p>Additionally, the formation of filopodia and lamellipodia, which is reported to be intimately related to the actomyosin dynamics and the activity of small Rho GTPases such as CDC42 (<xref ref-type="bibr" rid="bib4">Barry et al., 2015</xref>; <xref ref-type="bibr" rid="bib88">Zihni et al., 2016</xref>), is significantly reduced in <italic>CAPSL</italic>-defective HRECs. In our study, we confirmed that the knockdown of <italic>CAPSL</italic> led to a significant reduction of CDC42, which might be the causative mechanism behind the disturbed formation of filopodia and lamellipodia (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><p>Taken together, our study demonstrated that <italic>CAPSL</italic> is potentially a novel candidate gene associated with FEVR. We also demonstrated that variants in the <italic>CAPSL</italic> gene, independently of canonical Norrin/β-catenin signaling, cause FEVR through inactivating MYC signaling, expanding FEVR-involved signaling pathways.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>DNA sequencing of patients and controls</title><p>The study was approved by the Institutional Research Committees of Sichuan Provincial People’s Hospital (approval number: NSFC2014-009). Informed consent was obtained from all participants and from guardians of minors involved in genetic testing. The patients were clinically diagnosed with exudative vitreoretinopathy. Genomic DNA was extracted from the peripheral blood of FEVR families and control individuals using a blood DNA extraction kit (QIAGEN, Germantown, Maryland, USA) according to standard protocol. WES was performed on DNA samples to identify candidate pathogenic genes for FEVR as previously described (<xref ref-type="bibr" rid="bib87">Zhu et al., 2021</xref>). Family ID numbers 3036 and 3104 are not known to anyone outside the research group.</p></sec><sec id="s4-2"><title>Mouse model and genotyping</title><p><italic>Capsl</italic><sup>loxp/+</sup> (named <italic>Capsl<sup>em1Zxj</sup></italic>) model was generated using the CRISPR/Cas9 nickase technique by Viewsolid Biotechology (Beijing, China) in C57BL/6J background. The gRNA sequence was as follows: Capsl-L gRNA: 5′-<named-content content-type="sequence">CTATCCCAA</named-content> <named-content content-type="sequence">TTGTGCTCCTGG</named-content>-3′; Capsl-R gRNA: 5′-<named-content content-type="sequence">TGGGACTCATGGTTCTAGAGG</named-content>-3′. Pdgfb-iCreER (<xref ref-type="bibr" rid="bib14">Claxton et al., 2008</xref>) transgenic mice on a mixed background of C57BL/6 and CBA was obtainted from Dr. Marcus Fruttiger and backcrossed to background for 6 generations. <italic>Capsl</italic><sup>loxp/+</sup> mice were bred with Pdgfb-iCreER (<xref ref-type="bibr" rid="bib14">Claxton et al., 2008</xref>) transgenic mice to generate <italic>Capsl<sup>loxp/loxp</sup></italic>, Pdgfb-iCreER mice. Genomic DNA samples extracted from mouse tails were genotyped using PCR to detect loxp-flanked <italic>Capsl</italic> and Pdgfb-iCreER. Primer sets used for <italic>Capsl</italic> loxp were: 5′-<named-content content-type="sequence">GGCAGGTAAGATGGTGTC</named-content>-3′ and 5′-<named-content content-type="sequence">TCTGTTTGTGGATCAATGTG</named-content>-3′; and primer sets used for Pdgfb-iCreER were: 5′-<named-content content-type="sequence">GCCGCCGGGATCACTCTCG</named-content>-3′ and 5′-<named-content content-type="sequence">CCAGCCGCCGTCGCAACTC</named-content>-3′. All mice were maintained as breeding colonies with standard rodent water and diet in a 12:12-hr dark cycle under specific pathogen-free conditions, and both males and female mice were used for experimental analysis. Experiments involving animals were conducted in accordance with institutional guidelines and following the protocols approved by the Institutional Animal Care and Use Committee of Sichuan Provincial People’s Hospital (approval number: NSFC2014-009).</p></sec><sec id="s4-3"><title>Preparation of flat-mount retinae and retina sections</title><p>Enucleated eyes were fixed for 15 min in 4% paraformaldehyde (PFA) at room temperature, followed by immersion in phosphate buffered saline (PBS) for the same duration. The retinae were then dissected and partially cut into four quadrants as previously described (<xref ref-type="bibr" rid="bib53">Liu et al., 2022</xref>). The dissected retinal cups were post-fixed overnight and then stained as described below. As for retina sections, after fixation in 4% PFA for 2 hr, the enucleated eyes were dehydrated until they settled to the bottom of the tube with 30% sucrose and then embedded in Tissue Freezing Medium (Servicebio). Specimens were sectioned, cleaned, and stained as previously described (<xref ref-type="bibr" rid="bib80">Yang et al., 2019</xref>).</p></sec><sec id="s4-4"><title>Hyaloid vessel preparation</title><p>Neonatal eyes were fixed in 4% PFA for 2 hr before the cornea, lens, and iris were removed. The eye cup was immersed in 5% gelatin at 4°C overnight. The solidified gelatin was extricated and heat melted on a glass slide, washed with warm water, air-dried, and imaged with DAPI staining.</p></sec><sec id="s4-5"><title>Immunohistochemistry</title><p>All immunostainings of retinae were performed using littermates with similar body size and treated under the same conditions. The flat-mount retina and retina sections were permeabilized and blocked in PBS containing 5% fetal bovine serum and 0.2% Triton X-100 at room temperature for 2 hr. Next, they were rinsed in PBS and incubated in directly conjugated IB4 Alexa 488 or Alexa 594 (1:200; Thermo Fisher, USA) and primary antibodies in a blocking buffer at 4°C overnight. After three washes, the retinae were processed for multiple labeling or flat mounted onto microscope glass slides with Fluoromount (Sigma-Aldrich, USA).</p><p>For in vivo analysis of cell proliferation, each pup was injected intraperitoneally with 200 µg EdU 3 hr before the mice were euthanasia. Retinae were dissected and permeabilized as previously described. EDU-positive labeling was stained and detected by means of a Click-iT EDU Alexa Fluor-647 Imaging Kit (C10640, Thermo Fisher Scientific, USA) according to the manufacturer’s instruction. For paracellular BRB integrity analysis, each pup was injected intraperitoneally with 2% fluorescent tracer, 5-(and-6)-tetramethylrhodamine biocytin, biocytin-TMR (CAT#T12921, Thermo Fisher Scientific, USA) for 24 hr prior to sacrifice, followed by flat-mount preparation, blocking, and staining of Isolectin B4.</p><p>Images of stained flat-mounted retinae, retina sections, and HRECs were acquired using Zeiss LSM 800 confocal microscope (Thornwood, NY, USA) and processed with Zeiss processing software, Angio Tool, and Adobe Photoshop. The detailed information about antibodies used for immunofluorescence is listed in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>.</p></sec><sec id="s4-6"><title>Cell lines and primary cell culture</title><p>HRECs were purchased from Cell System and cultured in EBM-2 media (CC-3156, Lonza, Switzerland) containing 5% fetal bovine serum, 0.4% hydrocortisone, 4% Hfgf-b, 0.1% vascular endothelial growth factor (VEGF), 0.1% R3-IGF, 0.1% ascorbic acid, 0.1% human epidermal growth factor (hEGF) 0.1% GA-1000, and 0.1% heparin at 37°C in a 5% CO<sub>2</sub> incubator. HRECs at passages 3–7 were used for experiments.</p><p>HEK-293T and HEK-293STF were obtained from the American Type Culture Collection (ATCC) and cultured in Dulbecco's Modified Eagle Medium (DMEM) (SH30023.01, Hycolon, USA) with 10% fetal bovine serum and cells were maintained at 37°C in a 5% CO<sub>2</sub> incubator. Both cell lines were authenticated by STR profiling, and no mycoplasma contamination was found.</p></sec><sec id="s4-7"><title>Gene knockdown and overexpression strategies</title><p>HRECs were seeded on 6 cm dishes at the day before transfected with lentivirus carrying shRNA for human <italic>CAPSL</italic> (5′-<named-content content-type="sequence">AAGACCTTCGTGAAGTATA</named-content>-3′, Genechem, Shanghai, China) or negative control shRNA (5′-<named-content content-type="sequence">TTCTCCGAACGTGTCACGT</named-content>-3′) according to the protocol of the manufacture. Cells were incubated for at least 72 hr before used for further experiments.</p><p>For overexpression of exogenous protein in HEK-293T cells, cells were transfected with Lipofectamine-3000 (Invitrogen, USA) according to the manufacturer’s instructions.</p></sec><sec id="s4-8"><title>Matrigel EC tube formation assay</title><p>HRECs transfected with the corresponding shRNA after 72 hr were counted and planted onto the matrigel as previously described (<xref ref-type="bibr" rid="bib84">Zhang et al., 2019</xref>). After 6 hr of incubation at 37°C in a 5% CO<sub>2</sub> incubator, the images were captured under an anatomical lens (Carl Zeiss, Germany).</p></sec><sec id="s4-9"><title>Immunofluorescence of HREC</title><p>After cell counting, the same number of HRECs transfected with shCtrl and shCAPSL was seeded on slides in 24-well plates. Cells were fixed with 4% PFA at room temperature for 15 min. After being rinsed in PBS three times, cells were blocked in the blocking buffer at room temperature for 2 hr. The cells were labeled with primary antibodies overnight at 4°C. Following three washes in PBS, Alexa-Fluor-594- or Alexa-Fluor-647-conjugated antibodies were administered along with DAPI, and cells were incubated at room temperature for 1 hr. After three washes in PBS, stained cells were mounted on microscope glass slides with Fluoromount (Sigma-Aldrich, USA).</p><p>For in vitro analysis of cell proliferation, 20 μM EdU (Thermo Fisher Scientific, USA) was added into 96-well plated 3 hr before cells were harvested. EdU-positive cells were stained and detected with the Click-iT EDU Alexa Fluor-647 Imaging Kit (C10640, Thermo Fisher Scientific, USA) according to the manufacturer’s instruction.</p></sec><sec id="s4-10"><title>Wound healing assay</title><p>Seventy-two hours after shRNA transfection, HRECs were seeded in 6-well plates with complete medium for 24 hr until grown to confluence. Plates were then coated with 10 μg/ml fibronectin for half an hour in 37°C before cell culture. 200 μl pipette tips were used to generate wounds, and each well was washed twice with Utrasalin A (Lonza, Switzerland) to remove detached cells. Cells were then starved in the EBM-2 medium at 37°C in a 5% CO<sub>2</sub> incubator. Images of the wounds were captured with an optical microscope at 0, 12, and 16 hr after the wounds were made, respectively. The wound closure areas were measured using ImageJ software.</p><p>For analyses of Golgi apparatus polarization, cells were maintained on 24-well glass slides and fixed with 4% PFA for 15 min at 9 hr after cell migration was initiated.</p></sec><sec id="s4-11"><title>RNA extraction and RT-qPCR</title><p>Total RNA was extracted from cultured HRECs or fresh lungs from mouse using TRIzol reagent (Life Technologies, USA) according to the manufacturer’s instructions. RNA concentration and quality were measured with NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, USA), and 1 μg total RNA was reverse transcribed using EasyScript One-Step RT-PCR SuperMix (TransGen Biotech, Beijing, China) following the standard protocol. RT-qPCR was performed using a 7500 Real-Time PCR System (Applied Biosystems, USA) with TransStart Tip Green qPCR Supermix (TransGen Biotech). At least three experiments were performed, and PCR reactions were performed in triplicate. Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) was used as a reference gene. The primer sets are listed in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>. All experiments were replicated three times and representative results were shown.</p></sec><sec id="s4-12"><title>Protein extraction and western blotting</title><p>HRECs or lung tissue from mice were lysed in standard radioimmunoprecipitation assay buffer (PIPA, 50 mM Tris–HCl, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, pH 7.4) supplemented with Protease and Phosphatase Inhibitor Cocktail (Roche, USA). After sonication, centrifugation, and protein quantification, the supernatant was diluted in 2× sodium dodecyl sulfate (SDS) loading buffer. Equal amounts of protein (20 μg) were loaded and resolved on 10–15% SDS–polyacrylamide, and western blotting was performed. After gels were transfected onto a polyvinylidene difluoride membrane (GE Healthcare, USA), the membranes were incubated in a blocking buffer containing 8% skimmed milk (9999, Cell Signaling Technology) in tris buffered saline with Tween 20 (TBST) for 1 hr at room temperature on a rocking platform, followed by overnight incubation at 4°C with the primary antibodies diluted in blocking buffer. Membranes were then washed in TBST three times and incubated in the blocking buffer containing secondary Horseradish Peroxidase-conjugated antibodies for 1 hr at room temperature. Protein blots were visualized with e-BLOT Touch Imager (e-BLOT, China) and blots were relatively quantified with ImageJ. GAPDH was used as an internal reference. Detailed information about antibodies used for western blot is listed in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>. All experiments were replicated three times and representative blot images were shown.</p></sec><sec id="s4-13"><title>Luciferase assays</title><p>Dual-luciferase assays were performed as previously described (<xref ref-type="bibr" rid="bib87">Zhu et al., 2021</xref>). Briefly, 293STF cells were plated on 24-well plates at a confluency of ~30%. The following day, the cells were transfected with corresponding plasmids with lip3000. Forty-eight hours post-transfection, cells were harvested, and the lysates were used to measure Firefly and <italic>Renilla</italic> luciferase activity according to the manufacturer’s instructions (TransGen, Bejing, China).</p></sec><sec id="s4-14"><title>Quantification of retinal parameters</title><p>All quantifications were done using Zeiss processing software on high-resolution confocal images. Vascular progression was measured in a straight line from the optic nerve to the angiogenic front of the retinal plexus for each retina quadrant (<italic>n</italic> = 6, each group). Vessel density and branch points were calculated with Angio Tool software from flat-mounted retinae (<italic>n</italic> = 6, each group). Endothelial tip cell numbers were measured by counting endothelial sprouts at the angiogenic front of the entire vascular plexus of the same length (<italic>n</italic> = 6, each group). Endothelial tip cell filopodia density was calculated with high-resolution images (×60 objective) of six randomly selected angiogenic front fields from six retinae per genotype (<italic>n</italic> = 6, each group). EC proliferation was calculated by measuring the number of both EDU- and ERG-positive cells within retinae of the same size and same position at the edge of the vascular plexus (<italic>n</italic> = 6, each group). Retinal pericyte coverage was quantified by comparing the NG2<sup>+</sup> or Desmin<sup>+</sup> pericytes with IB4<sup>+</sup> vessels (<italic>n</italic> = 6, each group). The nuclear ellipticity of the cells at the scratch edge was calculated by the distance of the nuclear long axis (Height) divided by the maximum vertical distance to the nuclear long axis (Width).</p></sec><sec id="s4-15"><title>Transcriptomic profiling</title><p>Total RNA was extracted from shCtrl-ECs, sh<italic>CAPSL</italic>-ECs, and LentiOE-ECs and quantified using NanoDrop2000 Spectrophotometer (Thermo Fisher Scientific, USA). RNA integrity was determined by Bioanalyzer RNA 6000 Nano assay kit (Agilent, China). RNA library construction was performed with Illumina TruseqTM RNA sample prep Kit and RNA-seq was performed with Truseq SBS Kit (300 cycles) in BIOZERON (BIOZERON, China). RNA-seq reads were performed using the TopHat software tool to acquire the alignment file, which was used to quantify mRNA expression and determine the differentially expressed genes. All gene expression values were changed to log2 values for further analysis, and a p-value of less than or equal to 0.05 was considered to indicate significance. The GSEA was performed with the omicshare platform (<ext-link ext-link-type="uri" xlink:href="https://www.omicshare.com">https://www.omicshare.com</ext-link>). The raw data have been uploaded to the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa/browse/HRA010305">https://ngdc.cncb.ac.cn/gsa/browse/HRA010305</ext-link>), and the assigned accession number was HRA010305.</p></sec><sec id="s4-16"><title>Proteomic profiling</title><p>Total protein was extracted from shCtrl-ECs, sh<italic>CAPSL</italic>-ECs, and LentiOE-ECs and quantified using a BCA protein quantification kit (Beyotime, China). Samples were sent to PTM Biolab (PTM Biolab, China) to perform proteomic profiling using 4D-Labelfree. All protein expression values were changed to log2 values for further analysis, with a corrected p-value &lt;0.05. The GSEA was performed with the omicshare platform (<ext-link ext-link-type="uri" xlink:href="https://www.omicshare.com">https://www.omicshare.com</ext-link>). The raw data have been uploaded to the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive">https://www.ebi.ac.uk/pride/archive</ext-link>), and the assigned accession number was PXD051696.</p></sec><sec id="s4-17"><title>Image acquisition and statistical analysis</title><p>Immunofluorescence images were obtained using a laser scanning microscope (LSM 900, Zeiss). Statistical analyses were performed with GraphPad Prism 8.0 software. Data were analyzed using the Student’s <italic>t</italic> test for comparison between two groups or one-way analysis of variance followed by Dunnett multiple comparison test for comparison of multiple groups, and plotted as mean ± SD. At least three independent experiments were performed. ImageJ was used to compare results for the tube formation assay experiments and bands of immunoblot. Results were considered significant when *p＜0.05, **p＜0.01, ***p＜0.001, or ****p＜0.0001. ‘ns’ stands for ‘no significance’.</p></sec><sec id="s4-18"><title>Study approval</title><p>This study was approved by the institutional review board of Sichuan Provincial People’s Hospital (approval number: NSFC2014-009) and Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and informed consent was obtained from all participants or legal guardians for minors. All animal studies were performed according to established ethical guidelines approved by the animal care committee of Sichuan Provincial People’s Hospital (approval number: NSFC2014-009).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Investigation, Methodology, Writing – original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Validation, Investigation</p></fn><fn fn-type="con" id="con3"><p>Data curation, Validation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Validation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Validation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Validation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Data curation, Supervision, Validation, Investigation, Project administration</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Validation, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Writing – original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The study was approved by the Institutional Research Committees of Sichuan Provincial People's Hospital (approval number: NSFC2014-009). Informed consent was obtained from all participants and from guardians of minors involved in genetic testing. The patients were clinically diagnosed with exudative vitreoretinopathy. Family ID numbers 3036 and 3104 are not known to anyone outside the research group.</p></fn><fn fn-type="other"><p>All experiments involving animals were conducted in accordance with institutional guidelines and following the protocols approved by the Institutional Animal Care and Use Committee of Sichuan Provincial People's Hospital (approval number: NSFC2014-009).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>The results of pathological prediction of CAPSL variants.</title></caption><media xlink:href="elife-96907-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>The differentially regulated genes in shCtrl-ECs and shCAPSL-ECs.</title></caption><media xlink:href="elife-96907-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Down-regulated genes shared in <italic>CAPSL</italic>-depleted HRECs and <italic>MYC</italic>-depleted HUVECs.</title></caption><media xlink:href="elife-96907-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>List of the antibodies used in this study.</title></caption><media xlink:href="elife-96907-supp4-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>List of the PCR primers used in this study.</title></caption><media xlink:href="elife-96907-supp5-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-96907-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data produced or analyzed in the present study are included in the manuscript and supplementary files. RNAseq data and Proteomic profiling data of shCtrl-ECs, shCAPSL-ECs, and LentiOE-ECs have been uploaded to the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa-human/browse/HRA007150">https://ngdc.cncb.ac.cn/gsa-human/browse/HRA007150</ext-link>) and EMBL-EBI Archive (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/PXD051696">https://www.ebi.ac.uk/pride/archive/PXD051696</ext-link>).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>yang</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Fei</surname><given-names>P</given-names></name><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zhenglin</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>RNA-seq raw data for CAPSL HRECs</data-title><source>Genome Sequence Archive</source><pub-id pub-id-type="accession" xlink:href="https://ngdc.cncb.ac.cn/gsa-human/browse/HRA007150">HRA007150</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Fei</surname><given-names>P</given-names></name><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Proteomic raw data for ctrl HRECs, CAPSL knockdown HRECs,and CAPSL overexpression HRECs</data-title><source>PRIDE</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD051696">PXD051696</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adhikary</surname><given-names>S</given-names></name><name><surname>Eilers</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Transcriptional regulation and transformation by Myc proteins</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>6</volume><fpage>635</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1038/nrm1703</pub-id><pub-id pub-id-type="pmid">16064138</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Costa</surname><given-names>ASH</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Doddaballapur</surname><given-names>A</given-names></name><name><surname>Sugino</surname><given-names>T</given-names></name><name><surname>Ong</surname><given-names>YT</given-names></name><name><surname>Castro</surname><given-names>M</given-names></name><name><surname>Zimmermann</surname><given-names>B</given-names></name><name><surname>Kaulich</surname><given-names>M</given-names></name><name><surname>Guenther</surname><given-names>S</given-names></name><name><surname>Wilhelm</surname><given-names>K</given-names></name><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Koh</surname><given-names>GY</given-names></name><name><surname>Grosso</surname><given-names>AR</given-names></name><name><surname>Frezza</surname><given-names>C</given-names></name><name><surname>Potente</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Control of endothelial quiescence by FOXO-regulated metabolites</article-title><source>Nature Cell Biology</source><volume>23</volume><fpage>413</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1038/s41556-021-00637-6</pub-id><pub-id pub-id-type="pmid">33795871</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Oku</surname><given-names>K</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Familial exudative vitreoretinopathy with <italic>TGFBR2</italic> mutation without signs of Loeys-Dietz syndrome</article-title><source>Ophthalmic Genetics</source><volume>42</volume><fpage>637</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1080/13816810.2021.1938137</pub-id><pub-id pub-id-type="pmid">34102952</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>DM</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Meadows</surname><given-names>SM</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Norden</surname><given-names>PR</given-names></name><name><surname>Davis</surname><given-names>GE</given-names></name><name><surname>Cleaver</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cdc42 is required for cytoskeletal support of endothelial cell adhesion during blood vessel formation in mice</article-title><source>Development</source><volume>142</volume><fpage>3058</fpage><lpage>3070</lpage><pub-id pub-id-type="doi">10.1242/dev.125260</pub-id><pub-id pub-id-type="pmid">26253403</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baudino</surname><given-names>TA</given-names></name><name><surname>McKay</surname><given-names>C</given-names></name><name><surname>Pendeville-Samain</surname><given-names>H</given-names></name><name><surname>Nilsson</surname><given-names>JA</given-names></name><name><surname>Maclean</surname><given-names>KH</given-names></name><name><surname>White</surname><given-names>EL</given-names></name><name><surname>Davis</surname><given-names>AC</given-names></name><name><surname>Ihle</surname><given-names>JN</given-names></name><name><surname>Cleveland</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>2530</fpage><lpage>2543</lpage><pub-id pub-id-type="doi">10.1101/gad.1024602</pub-id><pub-id pub-id-type="pmid">12368264</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>M-E</given-names></name><name><surname>Castillo</surname><given-names>F</given-names></name><name><surname>Soucek</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural and biophysical insights into the function of the intrinsically disordered Myc Oncoprotein</article-title><source>Cells</source><volume>9</volume><elocation-id>1038</elocation-id><pub-id pub-id-type="doi">10.3390/cells9041038</pub-id><pub-id pub-id-type="pmid">32331235</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birdsey</surname><given-names>GM</given-names></name><name><surname>Shah</surname><given-names>AV</given-names></name><name><surname>Dufton</surname><given-names>N</given-names></name><name><surname>Reynolds</surname><given-names>LE</given-names></name><name><surname>Osuna Almagro</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Aspalter</surname><given-names>IM</given-names></name><name><surname>Khan</surname><given-names>ST</given-names></name><name><surname>Mason</surname><given-names>JC</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Hodivala-Dilke</surname><given-names>K</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name><name><surname>Randi</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-Catenin signaling</article-title><source>Developmental Cell</source><volume>32</volume><fpage>82</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.11.016</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cairo</surname><given-names>S</given-names></name><name><surname>Armengol</surname><given-names>C</given-names></name><name><surname>Buendia</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Activation of Wnt and Myc signaling in hepatoblastoma</article-title><source>Frontiers in Bioscience</source><volume>4</volume><fpage>480</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.2741/393</pub-id><pub-id pub-id-type="pmid">22201888</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Jain</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases</article-title><source>Nature Reviews. Drug Discovery</source><volume>10</volume><fpage>417</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1038/nrd3455</pub-id><pub-id pub-id-type="pmid">21629292</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>PA</given-names></name><name><surname>Freie</surname><given-names>BW</given-names></name><name><surname>Mathsyaraja</surname><given-names>H</given-names></name><name><surname>Eisenman</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis</article-title><source>Frontiers of Medicine</source><volume>12</volume><fpage>412</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1007/s11684-018-0650-z</pub-id><pub-id pub-id-type="pmid">30054853</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>JR</given-names></name><name><surname>Fortunato</surname><given-names>IC</given-names></name><name><surname>Fonseca</surname><given-names>CG</given-names></name><name><surname>Pezzarossa</surname><given-names>A</given-names></name><name><surname>Barbacena</surname><given-names>P</given-names></name><name><surname>Dominguez-Cejudo</surname><given-names>MA</given-names></name><name><surname>Vasconcelos</surname><given-names>FF</given-names></name><name><surname>Santos</surname><given-names>NC</given-names></name><name><surname>Carvalho</surname><given-names>FA</given-names></name><name><surname>Franco</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration</article-title><source>eLife</source><volume>8</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.45853</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>ZY</given-names></name><name><surname>Battinelli</surname><given-names>EM</given-names></name><name><surname>Fielder</surname><given-names>A</given-names></name><name><surname>Bundey</surname><given-names>S</given-names></name><name><surname>Sims</surname><given-names>K</given-names></name><name><surname>Breakefield</surname><given-names>XO</given-names></name><name><surname>Craig</surname><given-names>IW</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy</article-title><source>Nature Genetics</source><volume>5</volume><fpage>180</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1038/ng1093-180</pub-id><pub-id pub-id-type="pmid">8252044</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Stahl</surname><given-names>A</given-names></name><name><surname>Krah</surname><given-names>NM</given-names></name><name><surname>Seaward</surname><given-names>MR</given-names></name><name><surname>Joyal</surname><given-names>J-S</given-names></name><name><surname>Juan</surname><given-names>AM</given-names></name><name><surname>Hatton</surname><given-names>CJ</given-names></name><name><surname>Aderman</surname><given-names>CM</given-names></name><name><surname>Dennison</surname><given-names>RJ</given-names></name><name><surname>Willett</surname><given-names>KL</given-names></name><name><surname>Sapieha</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>LEH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e30203</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0030203</pub-id><pub-id pub-id-type="pmid">22272305</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claxton</surname><given-names>S</given-names></name><name><surname>Kostourou</surname><given-names>V</given-names></name><name><surname>Jadeja</surname><given-names>S</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Hodivala-Dilke</surname><given-names>K</given-names></name><name><surname>Fruttiger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Efficient, inducible cre-recombinase activation in vascular endothelium</article-title><source>Genesis</source><volume>46</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1002/dvg.20367</pub-id><pub-id pub-id-type="pmid">18257043</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collin</surname><given-names>RWJ</given-names></name><name><surname>Nikopoulos</surname><given-names>K</given-names></name><name><surname>Dona</surname><given-names>M</given-names></name><name><surname>Gilissen</surname><given-names>C</given-names></name><name><surname>Hoischen</surname><given-names>A</given-names></name><name><surname>Boonstra</surname><given-names>FN</given-names></name><name><surname>Poulter</surname><given-names>JA</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name><name><surname>Berger</surname><given-names>W</given-names></name><name><surname>Toomes</surname><given-names>C</given-names></name><name><surname>Tahira</surname><given-names>T</given-names></name><name><surname>Mohn</surname><given-names>LR</given-names></name><name><surname>Blokland</surname><given-names>EA</given-names></name><name><surname>Hetterschijt</surname><given-names>L</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name><name><surname>Groothuismink</surname><given-names>JM</given-names></name><name><surname>Duijkers</surname><given-names>L</given-names></name><name><surname>Inglehearn</surname><given-names>CF</given-names></name><name><surname>Sollfrank</surname><given-names>L</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name><name><surname>Uchio</surname><given-names>E</given-names></name><name><surname>van Nouhuys</surname><given-names>CE</given-names></name><name><surname>Kremer</surname><given-names>H</given-names></name><name><surname>Veltman</surname><given-names>JA</given-names></name><name><surname>van Wijk</surname><given-names>E</given-names></name><name><surname>Cremers</surname><given-names>FPM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature</article-title><source>PNAS</source><volume>110</volume><fpage>9856</fpage><lpage>9861</lpage><pub-id pub-id-type="doi">10.1073/pnas.1220864110</pub-id><pub-id pub-id-type="pmid">23716654</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coxam</surname><given-names>B</given-names></name><name><surname>Sabine</surname><given-names>A</given-names></name><name><surname>Bower</surname><given-names>NI</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Pichol-Thievend</surname><given-names>C</given-names></name><name><surname>Skoczylas</surname><given-names>R</given-names></name><name><surname>Astin</surname><given-names>JW</given-names></name><name><surname>Frampton</surname><given-names>E</given-names></name><name><surname>Jaquet</surname><given-names>M</given-names></name><name><surname>Crosier</surname><given-names>PS</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Harvey</surname><given-names>NL</given-names></name><name><surname>Petrova</surname><given-names>TV</given-names></name><name><surname>Schulte-Merker</surname><given-names>S</given-names></name><name><surname>Francois</surname><given-names>M</given-names></name><name><surname>Hogan</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pkd1 regulates lymphatic vascular morphogenesis during development</article-title><source>Cell Reports</source><volume>7</volume><fpage>623</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.03.063</pub-id><pub-id pub-id-type="pmid">24767999</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MYC on the Path to Cancer</article-title><source>Cell</source><volume>149</volume><fpage>22</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.03.003</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MYC, metabolism, cell growth, and tumorigenesis</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>3</volume><elocation-id>a014217</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a014217</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A time for MYC: metabolism and therapy</article-title><conf-name>Cold Spring Harbor Symposia on Quantitative Biology</conf-name><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1101/sqb.2016.81.031153</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Alboran</surname><given-names>IM</given-names></name><name><surname>O’Hagan</surname><given-names>RC</given-names></name><name><surname>Gärtner</surname><given-names>F</given-names></name><name><surname>Malynn</surname><given-names>B</given-names></name><name><surname>Davidson</surname><given-names>L</given-names></name><name><surname>Rickert</surname><given-names>R</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of C-MYC function in normal cells via conditional gene-targeted mutation</article-title><source>Immunity</source><volume>14</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(01)00088-7</pub-id><pub-id pub-id-type="pmid">11163229</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Crecchio</surname><given-names>G</given-names></name><name><surname>Simonelli</surname><given-names>F</given-names></name><name><surname>Nunziata</surname><given-names>G</given-names></name><name><surname>Mazzeo</surname><given-names>S</given-names></name><name><surname>Greco</surname><given-names>GM</given-names></name><name><surname>Rinaldi</surname><given-names>E</given-names></name><name><surname>Ventruto</surname><given-names>V</given-names></name><name><surname>Ciccodicola</surname><given-names>A</given-names></name><name><surname>Miano</surname><given-names>MG</given-names></name><name><surname>Testa</surname><given-names>F</given-names></name><name><surname>Curci</surname><given-names>A</given-names></name><name><surname>D’Urso</surname><given-names>M</given-names></name><name><surname>Rinaldi</surname><given-names>MM</given-names></name><name><surname>Cavaliere</surname><given-names>ML</given-names></name><name><surname>Castelluccio</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity</article-title><source>Clinical Genetics</source><volume>54</volume><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1034/j.1399-0004.1998.5440409.x</pub-id><pub-id pub-id-type="pmid">9831343</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Smet</surname><given-names>F</given-names></name><name><surname>Segura</surname><given-names>I</given-names></name><name><surname>De Bock</surname><given-names>K</given-names></name><name><surname>Hohensinner</surname><given-names>PJ</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>29</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.109.185165</pub-id><pub-id pub-id-type="pmid">19265031</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorrell</surname><given-names>MI</given-names></name><name><surname>Aguilar</surname><given-names>E</given-names></name><name><surname>Friedlander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>43</volume><fpage>3500</fpage><lpage>3510</lpage><pub-id pub-id-type="pmid">12407162</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downey</surname><given-names>LM</given-names></name><name><surname>Keen</surname><given-names>TJ</given-names></name><name><surname>Roberts</surname><given-names>E</given-names></name><name><surname>Mansfield</surname><given-names>DC</given-names></name><name><surname>Bamashmus</surname><given-names>M</given-names></name><name><surname>Inglehearn</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13</article-title><source>American Journal of Human Genetics</source><volume>68</volume><fpage>778</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1086/318790</pub-id><pub-id pub-id-type="pmid">11179025</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fallah</surname><given-names>A</given-names></name><name><surname>Sadeghinia</surname><given-names>A</given-names></name><name><surname>Kahroba</surname><given-names>H</given-names></name><name><surname>Samadi</surname><given-names>A</given-names></name><name><surname>Heidari</surname><given-names>HR</given-names></name><name><surname>Bradaran</surname><given-names>B</given-names></name><name><surname>Zeinali</surname><given-names>S</given-names></name><name><surname>Molavi</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases</article-title><source>Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie</source><volume>110</volume><fpage>775</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.12.022</pub-id><pub-id pub-id-type="pmid">30554116</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xian</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Early detection of ocular abnormalities in a Chinese multicentre neonatal eye screening programme-1-year result</article-title><source>Acta Ophthalmologica</source><volume>99</volume><fpage>e415</fpage><lpage>e422</lpage><pub-id pub-id-type="doi">10.1111/aos.14586</pub-id><pub-id pub-id-type="pmid">32930484</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>RS</given-names></name><name><surname>Gardel</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Adelstein</surname><given-names>RS</given-names></name><name><surname>Waterman</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Local cortical tension by myosin II guides 3D endothelial cell branching</article-title><source>Current Biology</source><volume>19</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2008.12.045</pub-id><pub-id pub-id-type="pmid">19185493</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraccaroli</surname><given-names>A</given-names></name><name><surname>Pitter</surname><given-names>B</given-names></name><name><surname>Taha</surname><given-names>AA</given-names></name><name><surname>Seebach</surname><given-names>J</given-names></name><name><surname>Huveneers</surname><given-names>S</given-names></name><name><surname>Kirsch</surname><given-names>J</given-names></name><name><surname>Casaroli-Marano</surname><given-names>RP</given-names></name><name><surname>Zahler</surname><given-names>S</given-names></name><name><surname>Pohl</surname><given-names>U</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Schnittler</surname><given-names>H-J</given-names></name><name><surname>Montanez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endothelial alpha-parvin controls integrity of developing vasculature and is required for maintenance of cell-cell junctions</article-title><source>Circulation Research</source><volume>117</volume><fpage>29</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.305818</pub-id><pub-id pub-id-type="pmid">25925587</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>CA</given-names></name><name><surname>Jones</surname><given-names>ML</given-names></name><name><surname>Bernabeu</surname><given-names>MO</given-names></name><name><surname>Geudens</surname><given-names>I</given-names></name><name><surname>Mathivet</surname><given-names>T</given-names></name><name><surname>Rosa</surname><given-names>A</given-names></name><name><surname>Lopes</surname><given-names>FM</given-names></name><name><surname>Lima</surname><given-names>AP</given-names></name><name><surname>Ragab</surname><given-names>A</given-names></name><name><surname>Collins</surname><given-names>RT</given-names></name><name><surname>Phng</surname><given-names>L-K</given-names></name><name><surname>Coveney</surname><given-names>PV</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Correction: dynamic endothelial cell rearrangements drive developmental vessel regression</article-title><source>PLOS Biology</source><volume>13</volume><elocation-id>e1002163</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1002163</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fruttiger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Development of the retinal vasculature</article-title><source>Angiogenesis</source><volume>10</volume><fpage>77</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1007/s10456-007-9065-1</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Sekiguchi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Rac regulates integrin-mediated endothelial cell adhesion and migration on laminin-8</article-title><source>Experimental Cell Research</source><volume>292</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2003.08.010</pub-id><pub-id pub-id-type="pmid">14720507</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Golding</surname><given-names>M</given-names></name><name><surname>Fruttiger</surname><given-names>M</given-names></name><name><surname>Ruhrberg</surname><given-names>C</given-names></name><name><surname>Lundkvist</surname><given-names>A</given-names></name><name><surname>Abramsson</surname><given-names>A</given-names></name><name><surname>Jeltsch</surname><given-names>M</given-names></name><name><surname>Mitchell</surname><given-names>C</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Shima</surname><given-names>D</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia</article-title><source>The Journal of Cell Biology</source><volume>161</volume><fpage>1163</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1083/jcb.200302047</pub-id><pub-id pub-id-type="pmid">12810700</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Slee</surname><given-names>RB</given-names></name><name><surname>Fukai</surname><given-names>N</given-names></name><name><surname>Rawadi</surname><given-names>G</given-names></name><name><surname>Roman-Roman</surname><given-names>S</given-names></name><name><surname>Reginato</surname><given-names>AM</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Cundy</surname><given-names>T</given-names></name><name><surname>Glorieux</surname><given-names>FH</given-names></name><name><surname>Lev</surname><given-names>D</given-names></name><name><surname>Zacharin</surname><given-names>M</given-names></name><name><surname>Oexle</surname><given-names>K</given-names></name><name><surname>Marcelino</surname><given-names>J</given-names></name><name><surname>Suwairi</surname><given-names>W</given-names></name><name><surname>Heeger</surname><given-names>S</given-names></name><name><surname>Sabatakos</surname><given-names>G</given-names></name><name><surname>Apte</surname><given-names>S</given-names></name><name><surname>Adkins</surname><given-names>WN</given-names></name><name><surname>Allgrove</surname><given-names>J</given-names></name><name><surname>Arslan-Kirchner</surname><given-names>M</given-names></name><name><surname>Batch</surname><given-names>JA</given-names></name><name><surname>Beighton</surname><given-names>P</given-names></name><name><surname>Black</surname><given-names>GC</given-names></name><name><surname>Boles</surname><given-names>RG</given-names></name><name><surname>Boon</surname><given-names>LM</given-names></name><name><surname>Borrone</surname><given-names>C</given-names></name><name><surname>Brunner</surname><given-names>HG</given-names></name><name><surname>Carle</surname><given-names>GF</given-names></name><name><surname>Dallapiccola</surname><given-names>B</given-names></name><name><surname>De Paepe</surname><given-names>A</given-names></name><name><surname>Floege</surname><given-names>B</given-names></name><name><surname>Halfhide</surname><given-names>ML</given-names></name><name><surname>Hall</surname><given-names>B</given-names></name><name><surname>Hennekam</surname><given-names>RC</given-names></name><name><surname>Hirose</surname><given-names>T</given-names></name><name><surname>Jans</surname><given-names>A</given-names></name><name><surname>Jüppner</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>CA</given-names></name><name><surname>Keppler-Noreuil</surname><given-names>K</given-names></name><name><surname>Kohlschuetter</surname><given-names>A</given-names></name><name><surname>LaCombe</surname><given-names>D</given-names></name><name><surname>Lambert</surname><given-names>M</given-names></name><name><surname>Lemyre</surname><given-names>E</given-names></name><name><surname>Letteboer</surname><given-names>T</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Ramesar</surname><given-names>RS</given-names></name><name><surname>Romanengo</surname><given-names>M</given-names></name><name><surname>Somer</surname><given-names>H</given-names></name><name><surname>Steichen-Gersdorf</surname><given-names>E</given-names></name><name><surname>Steinmann</surname><given-names>B</given-names></name><name><surname>Sullivan</surname><given-names>B</given-names></name><name><surname>Superti-Furga</surname><given-names>A</given-names></name><name><surname>Swoboda</surname><given-names>W</given-names></name><name><surname>van den Boogaard</surname><given-names>MJ</given-names></name><name><surname>Van Hul</surname><given-names>W</given-names></name><name><surname>Vikkula</surname><given-names>M</given-names></name><name><surname>Votruba</surname><given-names>M</given-names></name><name><surname>Zabel</surname><given-names>B</given-names></name><name><surname>Garcia</surname><given-names>T</given-names></name><name><surname>Baron</surname><given-names>R</given-names></name><name><surname>Olsen</surname><given-names>BR</given-names></name><name><surname>Warman</surname><given-names>ML</given-names></name><collab>Osteoporosis-Pseudoglioma Syndrome Collaborative Group</collab></person-group><year iso-8601-date="2001">2001</year><article-title>LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development</article-title><source>Cell</source><volume>107</volume><fpage>513</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)00571-2</pub-id><pub-id pub-id-type="pmid">11719191</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>J</given-names></name><name><surname>Oliver</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Familial exudative vitreoretinopathy: an expanded view</article-title><source>Archives of Ophthalmology</source><volume>86</volume><fpage>150</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1001/archopht.1971.01000010152007</pub-id><pub-id pub-id-type="pmid">5571414</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>S</given-names></name><name><surname>Hoover</surname><given-names>T</given-names></name><name><surname>Doss</surname><given-names>D</given-names></name><name><surname>Davidow</surname><given-names>K</given-names></name><name><surname>Walter</surname><given-names>AW</given-names></name><name><surname>Cottrell</surname><given-names>CE</given-names></name><name><surname>Mahapatra</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>WNT‐activated, MYC ‐amplified medulloblastoma displaying intratumoural heterogeneity</article-title><source>Neuropathology and Applied Neurobiology</source><volume>50</volume><elocation-id>e12945</elocation-id><pub-id pub-id-type="doi">10.1111/nan.12945</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Rho GTPases and the control of cell behaviour</article-title><source>Biochemical Society Transactions</source><volume>33</volume><fpage>891</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1042/BST20050891</pub-id><pub-id pub-id-type="pmid">16246005</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Dai</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Novel truncating variants in    <italic>CTNNB1</italic>    cause familial exudative vitreoretinopathy</article-title><source>Journal of Medical Genetics</source><volume>60</volume><fpage>174</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2021-108259</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellström</surname><given-names>M</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Kalén</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Eriksson</surname><given-names>U</given-names></name><name><surname>Wolburg</surname><given-names>H</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis</article-title><source>The Journal of Cell Biology</source><volume>153</volume><fpage>543</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1083/jcb.153.3.543</pub-id><pub-id pub-id-type="pmid">11331305</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Yoshioka</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Regression of the hyaloid vessels and pupillary membrane of the mouse</article-title><source>Anatomy and Embryology</source><volume>200</volume><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1007/s004290050289</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>X</given-names></name><name><surname>Ventruto</surname><given-names>V</given-names></name><name><surname>Trese</surname><given-names>MT</given-names></name><name><surname>Shastry</surname><given-names>BS</given-names></name><name><surname>Hejtmancik</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5</article-title><source>American Journal of Human Genetics</source><volume>75</volume><fpage>878</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1086/425080</pub-id><pub-id pub-id-type="pmid">15346351</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junge</surname><given-names>HJ</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Burton</surname><given-names>JB</given-names></name><name><surname>Paes</surname><given-names>K</given-names></name><name><surname>Shu</surname><given-names>X</given-names></name><name><surname>French</surname><given-names>DM</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name><name><surname>Rice</surname><given-names>DS</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling</article-title><source>Cell</source><volume>139</volume><fpage>299</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.07.048</pub-id><pub-id pub-id-type="pmid">19837033</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashani</surname><given-names>AH</given-names></name><name><surname>Learned</surname><given-names>D</given-names></name><name><surname>Nudleman</surname><given-names>E</given-names></name><name><surname>Drenser</surname><given-names>KA</given-names></name><name><surname>Capone</surname><given-names>A</given-names></name><name><surname>Trese</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy</article-title><source>Ophthalmology</source><volume>121</volume><fpage>262</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2013.08.010</pub-id><pub-id pub-id-type="pmid">24084499</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>K</given-names></name><name><surname>Logan</surname><given-names>CV</given-names></name><name><surname>McKibbin</surname><given-names>M</given-names></name><name><surname>Sheridan</surname><given-names>E</given-names></name><name><surname>Elçioglu</surname><given-names>NH</given-names></name><name><surname>Yenice</surname><given-names>O</given-names></name><name><surname>Parry</surname><given-names>DA</given-names></name><name><surname>Fernandez-Fuentes</surname><given-names>N</given-names></name><name><surname>Abdelhamed</surname><given-names>ZIA</given-names></name><name><surname>Al-Maskari</surname><given-names>A</given-names></name><name><surname>Poulter</surname><given-names>JA</given-names></name><name><surname>Mohamed</surname><given-names>MD</given-names></name><name><surname>Carr</surname><given-names>IM</given-names></name><name><surname>Morgan</surname><given-names>JE</given-names></name><name><surname>Jafri</surname><given-names>H</given-names></name><name><surname>Raashid</surname><given-names>Y</given-names></name><name><surname>Taylor</surname><given-names>GR</given-names></name><name><surname>Johnson</surname><given-names>CA</given-names></name><name><surname>Inglehearn</surname><given-names>CF</given-names></name><name><surname>Toomes</surname><given-names>C</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defects</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>776</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr509</pub-id><pub-id pub-id-type="pmid">22068589</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>MJ</given-names></name><name><surname>Hong</surname><given-names>SP</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Lim</surname><given-names>D-S</given-names></name><name><surname>Koh</surname><given-names>GY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A MST1–FOXO1 cascade establishes endothelial tip cell polarity and facilitates sprouting angiogenesis</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>838</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-08773-2</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knies-Bamforth</surname><given-names>UE</given-names></name><name><surname>Fox</surname><given-names>SB</given-names></name><name><surname>Poulsom</surname><given-names>R</given-names></name><name><surname>Evan</surname><given-names>GI</given-names></name><name><surname>Harris</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>c-Myc interacts with hypoxia to induce angiogenesis In vivo by a vascular endothelial growth factor-dependent mechanism</article-title><source>Cancer Research</source><volume>64</volume><fpage>6563</fpage><lpage>6570</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-03-3176</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowland</surname><given-names>D</given-names></name><name><surname>Arac</surname><given-names>A</given-names></name><name><surname>Sekiguchi</surname><given-names>KJ</given-names></name><name><surname>Hsu</surname><given-names>M</given-names></name><name><surname>Lutz</surname><given-names>SE</given-names></name><name><surname>Perrino</surname><given-names>J</given-names></name><name><surname>Steinberg</surname><given-names>GK</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Nimmerjahn</surname><given-names>A</given-names></name><name><surname>Agalliu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke</article-title><source>Neuron</source><volume>82</volume><fpage>603</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.03.003</pub-id><pub-id pub-id-type="pmid">24746419</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>H</given-names></name><name><surname>Gärtner</surname><given-names>T</given-names></name><name><surname>Eggli</surname><given-names>PS</given-names></name><name><surname>Christ</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>First blood vessels in the avian neural tube are formed by a combination of dorsal angioblast immigration and ventral sprouting of endothelial cells</article-title><source>Developmental Biology</source><volume>173</volume><fpage>133</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1006/dbio.1996.0012</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>H-B</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Helker</surname><given-names>CSM</given-names></name><name><surname>Rasouli</surname><given-names>SJ</given-names></name><name><surname>Maischein</surname><given-names>H-M</given-names></name><name><surname>Offermanns</surname><given-names>S</given-names></name><name><surname>Herzog</surname><given-names>W</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In vivo modulation of endothelial polarization by Apelin receptor signalling</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11805</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11805</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Sundaresan</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Variants in the Wnt co-receptor LRP6 are associated with familial exudative vitreoretinopathy</article-title><source>Journal of Genetics and Genomics = Yi Chuan Xue Bao</source><volume>49</volume><fpage>590</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/j.jgg.2021.11.010</pub-id><pub-id pub-id-type="pmid">34896607</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy</article-title><source>Genes &amp; Diseases</source><volume>10</volume><fpage>2572</fpage><lpage>2585</lpage><pub-id pub-id-type="doi">10.1016/j.gendis.2022.10.003</pub-id><pub-id pub-id-type="pmid">37554197</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>A</given-names></name><name><surname>Marbach</surname><given-names>F</given-names></name><name><surname>Tschernitz</surname><given-names>S</given-names></name><name><surname>Ortner</surname><given-names>C</given-names></name><name><surname>Berneburg</surname><given-names>M</given-names></name><name><surname>Felthaus</surname><given-names>O</given-names></name><name><surname>Prantl</surname><given-names>L</given-names></name><name><surname>Kye</surname><given-names>MJ</given-names></name><name><surname>Rappl</surname><given-names>G</given-names></name><name><surname>Altmüller</surname><given-names>J</given-names></name><name><surname>Thiele</surname><given-names>H</given-names></name><name><surname>Schreml</surname><given-names>S</given-names></name><name><surname>Schreml</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Calcyphosine-like (CAPSL) is regulated in Multiple Symmetric Lipomatosis and is involved in Adipogenesis</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>8444</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-44382-1</pub-id><pub-id pub-id-type="pmid">31186450</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Senger</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells</article-title><source>FASEB Journal</source><volume>18</volume><fpage>457</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1096/fj.03-0948com</pub-id><pub-id pub-id-type="pmid">15003991</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>LMBR1L regulates the proliferation and migration of endothelial cells through Norrin/β-catenin signaling</article-title><source>Journal of Cell Science</source><volume>135</volume><elocation-id>jcs259468</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.259468</pub-id><pub-id pub-id-type="pmid">35146515</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Frameshift variants in the C-terminal of CTNNB1 cause familial exudative vitreoretinopathy by AXIN1-mediated ubiquitin-proteasome degradation condensation</article-title><source>International Journal of Biological Macromolecules</source><volume>258</volume><elocation-id>128570</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.128570</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lourenco</surname><given-names>C</given-names></name><name><surname>Resetca</surname><given-names>D</given-names></name><name><surname>Redel</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>MacDonald</surname><given-names>AS</given-names></name><name><surname>Ciaccio</surname><given-names>R</given-names></name><name><surname>Kenney</surname><given-names>TMG</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Andrews</surname><given-names>DW</given-names></name><name><surname>Sunnerhagen</surname><given-names>M</given-names></name><name><surname>Arrowsmith</surname><given-names>CH</given-names></name><name><surname>Raught</surname><given-names>B</given-names></name><name><surname>Penn</surname><given-names>LZ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>MYC protein interactors in gene transcription and cancer</article-title><source>Nature Reviews. Cancer</source><volume>21</volume><fpage>579</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1038/s41568-021-00367-9</pub-id><pub-id pub-id-type="pmid">34188192</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luhmann</surname><given-names>UFO</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Acar</surname><given-names>N</given-names></name><name><surname>Lammel</surname><given-names>S</given-names></name><name><surname>Feil</surname><given-names>S</given-names></name><name><surname>Grimm</surname><given-names>C</given-names></name><name><surname>Seeliger</surname><given-names>MW</given-names></name><name><surname>Hammes</surname><given-names>H-P</given-names></name><name><surname>Berger</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>46</volume><fpage>3372</fpage><lpage>3382</lpage><pub-id pub-id-type="doi">10.1167/iovs.05-0174</pub-id><pub-id pub-id-type="pmid">16123442</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin‐Padilla</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Early vascularization of the embryonic cerebral cortex: Golgi and electron microscopic studies</article-title><source>Journal of Comparative Neurology</source><volume>241</volume><fpage>237</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1002/cne.902410210</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martowicz</surname><given-names>A</given-names></name><name><surname>Trusohamn</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>N</given-names></name><name><surname>Wisniewska-Kruk</surname><given-names>J</given-names></name><name><surname>Corada</surname><given-names>M</given-names></name><name><surname>Ning</surname><given-names>FC</given-names></name><name><surname>Kele</surname><given-names>J</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name><name><surname>Nyqvist</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Endothelial β-catenin signaling supports postnatal brain and retinal angiogenesis by promoting sprouting, tip cell formation, and VEGFR (Vascular Endothelial Growth Factor Receptor) 2 Expression</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>39</volume><fpage>2273</fpage><lpage>2288</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.119.312749</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikopoulos</surname><given-names>K</given-names></name><name><surname>Gilissen</surname><given-names>C</given-names></name><name><surname>Hoischen</surname><given-names>A</given-names></name><name><surname>van Nouhuys</surname><given-names>CE</given-names></name><name><surname>Boonstra</surname><given-names>FN</given-names></name><name><surname>Blokland</surname><given-names>EAW</given-names></name><name><surname>Arts</surname><given-names>P</given-names></name><name><surname>Wieskamp</surname><given-names>N</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name><name><surname>Ayuso</surname><given-names>C</given-names></name><name><surname>Tilanus</surname><given-names>MAD</given-names></name><name><surname>Bouwhuis</surname><given-names>S</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A</given-names></name><name><surname>Scheffer</surname><given-names>H</given-names></name><name><surname>Hoefsloot</surname><given-names>LH</given-names></name><name><surname>Veltman</surname><given-names>JA</given-names></name><name><surname>Cremers</surname><given-names>FPM</given-names></name><name><surname>Collin</surname><given-names>RWJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy</article-title><source>American Journal of Human Genetics</source><volume>86</volume><fpage>240</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2009.12.016</pub-id><pub-id pub-id-type="pmid">20159111</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panagiotou</surname><given-names>ES</given-names></name><name><surname>Sanjurjo Soriano</surname><given-names>C</given-names></name><name><surname>Poulter</surname><given-names>JA</given-names></name><name><surname>Lord</surname><given-names>EC</given-names></name><name><surname>Dzulova</surname><given-names>D</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name><name><surname>Hiyoshi</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>BH-Y</given-names></name><name><surname>Chu</surname><given-names>YW-Y</given-names></name><name><surname>Lai</surname><given-names>CHY</given-names></name><name><surname>Tafoya</surname><given-names>ME</given-names></name><name><surname>Karjosukarso</surname><given-names>D</given-names></name><name><surname>Collin</surname><given-names>RWJ</given-names></name><name><surname>Topping</surname><given-names>J</given-names></name><name><surname>Downey</surname><given-names>LM</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name><name><surname>Inglehearn</surname><given-names>CF</given-names></name><name><surname>Toomes</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Defects in the cell signaling mediator β-catenin cause the retinal vascular condition FEVR</article-title><source>American Journal of Human Genetics</source><volume>100</volume><fpage>960</fpage><lpage>968</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.05.001</pub-id><pub-id pub-id-type="pmid">28575650</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Mohn</surname><given-names>L</given-names></name><name><surname>Ambühl</surname><given-names>L</given-names></name><name><surname>Kanai</surname><given-names>K</given-names></name><name><surname>Schmidt</surname><given-names>I</given-names></name><name><surname>Kim</surname><given-names>K-P</given-names></name><name><surname>Fraccaroli</surname><given-names>A</given-names></name><name><surname>Feil</surname><given-names>S</given-names></name><name><surname>Junge</surname><given-names>HJ</given-names></name><name><surname>Montanez</surname><given-names>E</given-names></name><name><surname>Berger</surname><given-names>W</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Integrin-linked kinase controls retinal angiogenesis and is linked to Wnt signaling and exudative vitreoretinopathy</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>5243</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13220-3</pub-id><pub-id pub-id-type="pmid">31748531</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plager</surname><given-names>DA</given-names></name><name><surname>Orgel</surname><given-names>IK</given-names></name><name><surname>Ellis</surname><given-names>FD</given-names></name><name><surname>Hartzer</surname><given-names>M</given-names></name><name><surname>Trese</surname><given-names>MT</given-names></name><name><surname>Shastry</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>X-linked recessive familial exudative vitreoretinopathy</article-title><source>American Journal of Ophthalmology</source><volume>114</volume><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/S0002-9394(14)73977-7</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potente</surname><given-names>M</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Basic and therapeutic aspects of angiogenesis</article-title><source>Cell</source><volume>146</volume><fpage>873</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.08.039</pub-id><pub-id pub-id-type="pmid">21925313</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rattner</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Roles of HIFs and VEGF in angiogenesis in the retina and brain</article-title><source>The Journal of Clinical Investigation</source><volume>129</volume><fpage>3807</fpage><lpage>3820</lpage><pub-id pub-id-type="doi">10.1172/JCI126655</pub-id><pub-id pub-id-type="pmid">31403471</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rennoll</surname><given-names>S</given-names></name><name><surname>Yochum</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer</article-title><source>World Journal of Biological Chemistry</source><volume>6</volume><fpage>290</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.4331/wjbc.v6.i4.290</pub-id><pub-id pub-id-type="pmid">26629312</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robitaille</surname><given-names>J</given-names></name><name><surname>MacDonald</surname><given-names>MLE</given-names></name><name><surname>Kaykas</surname><given-names>A</given-names></name><name><surname>Sheldahl</surname><given-names>LC</given-names></name><name><surname>Zeisler</surname><given-names>J</given-names></name><name><surname>Dubé</surname><given-names>M-P</given-names></name><name><surname>Zhang</surname><given-names>L-H</given-names></name><name><surname>Singaraja</surname><given-names>RR</given-names></name><name><surname>Guernsey</surname><given-names>DL</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Siebert</surname><given-names>LF</given-names></name><name><surname>Hoskin-Mott</surname><given-names>A</given-names></name><name><surname>Trese</surname><given-names>MT</given-names></name><name><surname>Pimstone</surname><given-names>SN</given-names></name><name><surname>Shastry</surname><given-names>BS</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name><name><surname>Hayden</surname><given-names>MR</given-names></name><name><surname>Goldberg</surname><given-names>YP</given-names></name><name><surname>Samuels</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy</article-title><source>Nature Genetics</source><volume>32</volume><fpage>326</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/ng957</pub-id><pub-id pub-id-type="pmid">12172548</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robitaille</surname><given-names>JM</given-names></name><name><surname>Gillett</surname><given-names>RM</given-names></name><name><surname>LeBlanc</surname><given-names>MA</given-names></name><name><surname>Gaston</surname><given-names>D</given-names></name><name><surname>Nightingale</surname><given-names>M</given-names></name><name><surname>Mackley</surname><given-names>MP</given-names></name><name><surname>Parkash</surname><given-names>S</given-names></name><name><surname>Hathaway</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><name><surname>Ells</surname><given-names>A</given-names></name><name><surname>Traboulsi</surname><given-names>EI</given-names></name><name><surname>Héon</surname><given-names>E</given-names></name><name><surname>Roy</surname><given-names>M</given-names></name><name><surname>Shalev</surname><given-names>S</given-names></name><name><surname>Fernandez</surname><given-names>CV</given-names></name><name><surname>MacGillivray</surname><given-names>C</given-names></name><name><surname>Wallace</surname><given-names>K</given-names></name><name><surname>Fahiminiya</surname><given-names>S</given-names></name><name><surname>Majewski</surname><given-names>J</given-names></name><name><surname>McMaster</surname><given-names>CR</given-names></name><name><surname>Bedard</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phenotypic overlap between familial exudative vitreoretinopathy and microcephaly, lymphedema, and chorioretinal dysplasia caused by KIF11 mutations</article-title><source>JAMA Ophthalmology</source><volume>132</volume><fpage>1393</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2014.2814</pub-id><pub-id pub-id-type="pmid">25124931</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruhrberg</surname><given-names>C</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Golding</surname><given-names>M</given-names></name><name><surname>Watson</surname><given-names>R</given-names></name><name><surname>Ioannidou</surname><given-names>S</given-names></name><name><surname>Fujisawa</surname><given-names>H</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name><name><surname>Shima</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>2684</fpage><lpage>2698</lpage><pub-id pub-id-type="doi">10.1101/gad.242002</pub-id><pub-id pub-id-type="pmid">12381667</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saint-Geniez</surname><given-names>M</given-names></name><name><surname>D’amore</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Development and pathology of the hyaloid, choroidal and retinal vasculature</article-title><source>The International Journal of Developmental Biology</source><volume>48</volume><fpage>1045</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1387/ijdb.041895ms</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvo</surname><given-names>J</given-names></name><name><surname>Lyubasyuk</surname><given-names>V</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Nguyen</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Wen</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Next-generation sequencing and novel variant determination in a cohort of 92 familial exudative vitreoretinopathy patients</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>56</volume><fpage>1937</fpage><lpage>1946</lpage><pub-id pub-id-type="doi">10.1167/iovs.14-16065</pub-id><pub-id pub-id-type="pmid">25711638</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>S</given-names></name><name><surname>Calado</surname><given-names>DP</given-names></name><name><surname>Srinivasan</surname><given-names>L</given-names></name><name><surname>Köchert</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Rosolowski</surname><given-names>M</given-names></name><name><surname>Rodig</surname><given-names>SJ</given-names></name><name><surname>Holzmann</surname><given-names>K</given-names></name><name><surname>Stilgenbauer</surname><given-names>S</given-names></name><name><surname>Siebert</surname><given-names>R</given-names></name><name><surname>Bullinger</surname><given-names>L</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis</article-title><source>Cancer Cell</source><volume>22</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2012.06.012</pub-id><pub-id pub-id-type="pmid">22897848</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Oliveira</surname><given-names>P</given-names></name><name><surname>Correia</surname><given-names>A</given-names></name><name><surname>Rodrigues</surname><given-names>T</given-names></name><name><surname>Ribeiro-Rodrigues</surname><given-names>TM</given-names></name><name><surname>Matafome</surname><given-names>P</given-names></name><name><surname>Rodríguez-Manzaneque</surname><given-names>JC</given-names></name><name><surname>Seiça</surname><given-names>R</given-names></name><name><surname>Girão</surname><given-names>H</given-names></name><name><surname>Travasso</surname><given-names>RDM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The force at the tip--modelling tension and proliferation in sprouting angiogenesis</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004436</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004436</pub-id><pub-id pub-id-type="pmid">26248210</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvam</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>T</given-names></name><name><surname>Fruttiger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Retinal vasculature development in health and disease</article-title><source>Progress in Retinal and Eye Research</source><volume>63</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2017.11.001</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenzel</surname><given-names>D</given-names></name><name><surname>Lundkvist</surname><given-names>A</given-names></name><name><surname>Sauvaget</surname><given-names>D</given-names></name><name><surname>Busse</surname><given-names>M</given-names></name><name><surname>Graupera</surname><given-names>M</given-names></name><name><surname>van der Flier</surname><given-names>A</given-names></name><name><surname>Wijelath</surname><given-names>ES</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Sobel</surname><given-names>M</given-names></name><name><surname>Costell</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Fässler</surname><given-names>R</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Gutmann</surname><given-names>DH</given-names></name><name><surname>Hynes</surname><given-names>RO</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis</article-title><source>Development</source><volume>138</volume><fpage>4451</fpage><lpage>4463</lpage><pub-id pub-id-type="doi">10.1242/dev.071381</pub-id><pub-id pub-id-type="pmid">21880786</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stine</surname><given-names>ZE</given-names></name><name><surname>Walton</surname><given-names>ZE</given-names></name><name><surname>Altman</surname><given-names>BJ</given-names></name><name><surname>Hsieh</surname><given-names>AL</given-names></name><name><surname>Dang</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MYC, Metabolism, and Cancer</article-title><source>Cancer Discovery</source><volume>5</volume><fpage>1024</fpage><lpage>1039</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-15-0507</pub-id><pub-id pub-id-type="pmid">26382145</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogenstahl</surname><given-names>J</given-names></name><name><surname>Parrilla</surname><given-names>M</given-names></name><name><surname>Acker-Palmer</surname><given-names>A</given-names></name><name><surname>Segarra</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Vascular regulation of developmental neurogenesis</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>10</volume><elocation-id>890852</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2022.890852</pub-id><pub-id pub-id-type="pmid">35573692</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>K</given-names></name><name><surname>Happel</surname><given-names>K</given-names></name><name><surname>Eelen</surname><given-names>G</given-names></name><name><surname>Schoors</surname><given-names>S</given-names></name><name><surname>Oellerich</surname><given-names>MF</given-names></name><name><surname>Lim</surname><given-names>R</given-names></name><name><surname>Zimmermann</surname><given-names>B</given-names></name><name><surname>Aspalter</surname><given-names>IM</given-names></name><name><surname>Franco</surname><given-names>CA</given-names></name><name><surname>Boettger</surname><given-names>T</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Fruttiger</surname><given-names>M</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Brüning</surname><given-names>JC</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Potente</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FOXO1 couples metabolic activity and growth state in the vascular endothelium</article-title><source>Nature</source><volume>529</volume><fpage>216</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1038/nature16498</pub-id><pub-id pub-id-type="pmid">26735015</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>CH</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Cheung</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Chang</surname><given-names>B</given-names></name><name><surname>Beutler</surname><given-names>B</given-names></name><name><surname>Gong</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A model for familial exudative vitreoretinopathy caused by LPR5 mutations</article-title><source>Human Molecular Genetics</source><volume>17</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddn047</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Tao</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>An SNX31 variant underlies dominant familial exudative vitreoretinopathy-like pathogenesis</article-title><source>JCI Insight</source><volume>8</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.167032</pub-id><pub-id pub-id-type="pmid">37053012</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tmem30a deficiency leads to retinal rod bipolar cell degeneration</article-title><source>Journal of Neurochemistry</source><volume>148</volume><fpage>400</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1111/jnc.14643</pub-id><pub-id pub-id-type="pmid">30548540</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Dai</surname><given-names>E</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt/cadherin axis</article-title><source>JCI Insight</source><volume>7</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.158428</pub-id><pub-id pub-id-type="pmid">35700046</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cahill</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Badea</surname><given-names>TC</given-names></name><name><surname>Smallwood</surname><given-names>PM</given-names></name><name><surname>Peachey</surname><given-names>NS</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Norrin, Frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization</article-title><source>Cell</source><volume>139</volume><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.07.047</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonekawa</surname><given-names>Y</given-names></name><name><surname>Thomas</surname><given-names>BJ</given-names></name><name><surname>Drenser</surname><given-names>KA</given-names></name><name><surname>Trese</surname><given-names>MT</given-names></name><name><surname>Capone</surname><given-names>A</given-names><suffix>Jr</suffix></name></person-group><year iso-8601-date="2015">2015</year><article-title>Familial exudative vitreoretinopathy: spectral-domain optical coherence tomography of the vitreoretinal interface, retina, and choroid</article-title><source>Ophthalmology</source><volume>122</volume><fpage>2270</fpage><lpage>2277</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2015.07.024</pub-id><pub-id pub-id-type="pmid">26299697</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TMEM30A deficiency in endothelial cells impairs cell proliferation and angiogenesis</article-title><source>Journal of Cell Science</source><volume>132</volume><elocation-id>jcs225052</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.225052</pub-id><pub-id pub-id-type="pmid">30814335</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Fei</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Exome sequencing revealed Notch ligand JAG1 as a novel candidate gene for familial exudative vitreoretinopathy</article-title><source>Genetics in Medicine</source><volume>22</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/s41436-019-0571-5</pub-id><pub-id pub-id-type="pmid">31273345</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Fei</surname><given-names>P</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Whole-exome sequencing identified <italic>DLG1</italic> as a candidate gene for familial exudative vitreoretinopathy</article-title><source>Genetic Testing and Molecular Biomarkers</source><volume>25</volume><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1089/gtmb.2021.0013</pub-id><pub-id pub-id-type="pmid">33945310</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Fei</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Hao</surname><given-names>F</given-names></name><name><surname>Sundaresan</surname><given-names>P</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Catenin α 1 mutations cause familial exudative vitreoretinopathy by overactivating Norrin/β-catenin signaling</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e139869</elocation-id><pub-id pub-id-type="doi">10.1172/JCI139869</pub-id><pub-id pub-id-type="pmid">33497368</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zihni</surname><given-names>C</given-names></name><name><surname>Mills</surname><given-names>C</given-names></name><name><surname>Matter</surname><given-names>K</given-names></name><name><surname>Balda</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tight junctions: from simple barriers to multifunctional molecular gates</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>17</volume><fpage>564</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.80</pub-id><pub-id pub-id-type="pmid">27353478</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96907.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xiaorong</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Virginia</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This study explores the role of calcyphosine-like (CAPSL) in Familial Exudative Vitreoretinopathy (FEVR) via the MYC pathway, offering <bold>valuable</bold> insights into disease mechanisms that are supported by a solid, multi-pronged approach. The manuscript, which presents the phenotype of an interesting new mouse model, provides <bold>convincing</bold> evidence that CAPSL variants cause disease.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96907.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The author presents the discovery and characterization of CAPSL as a potential gene linked to Familial Exudative Vitreoretinopathy (FEVR), identifying one nonsense and one missense mutation within CAPSL in two distinct patient families afflicted by FEVR. Cell transfection assays suggest that the missense mutation adversely affects protein levels when overexpressed in cell cultures. Furthermore, conditionally knocking out CAPSL in vascular endothelial cells leads to compromised vascular development. The suppression of CAPSL in human retinal microvascular endothelial cells results in hindered tube formation, a decrease in cell proliferation, and disrupted cell polarity. Additionally, transcriptomic and proteomic profiling of these cells indicates alterations in the MYC pathway.</p><p>Strengths:</p><p>The study is nicely designed with a combination of in vivo and in vitro approaches, and the experimental results are good quality.</p><p>Weaknesses:</p><p>My reservations lie with the main assertion that CAPSL is associated with FEVR, as the genetic evidence from human studies appears relatively weak. Further careful examination of human genetics evidence in both patient cohorts and the general population will help to clarify. In light of human genetics, more caution needs to be exercised when interpreting results from mice and cell model and how is it related to the human patient phenotype. Future replication by finding more FEVR patients with a mutation in CAPSL will strengthen the findings.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96907.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This work identifies two variants in CAPSL in two generation familial exudative vitreoretinopathy (FEVR) pedigrees, and using a knockout mouse model, they link CAPSL to retinal vascular development and endothelial proliferation through the MYC pathway. Together, these findings suggest that the identified variants may be causative and that CAPSL is a new FEVR-associated gene.</p><p>Strengths:</p><p>The authors data provides compelling evidence that loss of the poorly understood protein CAPSL can lead to reduced endothelial proliferation in mouse retina and suppression of MYC signaling, consistent with the disease seen in FEVR patients. The paper is clearly written, and the data generally support the author's hypotheses.</p><p>Weaknesses:</p><p>(1) Both pedigrees described suggest autosomal dominant inheritance in humans, but no phenotype was observed in Capsl heterozygous mice. Additional studies would be needed to determine the cause of this disparity.</p><p>(2) Additional discussion of the hypothesized functional mechanism of the p.L83F variant would have improved the manuscript. While the human genetic data is compelling, it remains unclear how this variant may effect CAPSL function. In vitro, p.L83F protein appears to be normally localized within the cell and it is unclear why less mutant protein was detected in transfected cells. Was the modified protein targeted for degradation?</p><p>(3) Authors did not describe how the new crispr-generated Capsl-loxp mouse model was screened for potential off-target gene editing, raising the possibility that unrelated confounding mutations may have been introduced.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96907.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This manuscript by Liu et al. presents a case that CAPSL mutations are a cause of familial exudative vitreoretinopathy (FEVR). Attention was initially focused on the CAPSL gene from whole exome sequence analysis of two small families. The follow-up analyses included studies in which Capsl was manipulated in endothelial cells of mice and multiple iterations of molecular and cellular analyses. Together, the data show that CAPSL influences endothelial cell proliferation and migration. Molecularly, transcriptomic and proteomic analyses suggest that CAPSL influences many genes/proteins that are also downstream targets of MYC and may be important to the mechanisms.</p><p>Strengths:</p><p>This multi-pronged approach found a previously unknown function for CAPSL in endothelial cells and pointed at MYC pathways as high-quality candidates in the mechanism. Through the review process, some statements and interpretations were initially challenged. However, the issues were addressed with new experimentation and modifications to the text - leaving a strengthened presentation that makes a compelling case.</p><p>Weaknesses:</p><p>Two issues shape the overall impact for me. First, it remains unclear how common CAPSL variants may be in the human population. From the current study, it is possible that they are rare - perhaps limiting an immediate clinical impact. However, sharing the data may help identify additional variants in FEVR or other vascular diseases. The findings also make advances in basic biology which could ultimately contribute to therapies of broad relevance. Thus, this weakness is considered modest. Second, the links to the MYC axis are largely based on association, which will require additional experimentation to help understand.</p><p>One interesting technical point raised in the study, which might be missed without care by the readership, is that the variants appear to act dominantly in human families, but only act recessively in the mouse model. The authors cite other work from the field in which this same mismatch occurs, likely pointing to limits in how closely a mouse model might be expected to recapitulate a human disease. This technical point is likely relevant to ongoing studies of FEVR and many other multigenic diseases as well.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96907.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Wenjing</given-names></name><role specific-use="author">Author</role><aff><institution>University of Electronic Science and Technology of China</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Shujin</given-names></name><role specific-use="author">Author</role><aff><institution>Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People's Hospital</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Mu</given-names></name><role specific-use="author">Author</role><aff><institution>Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People's Hospital</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Jie</given-names></name><role specific-use="author">Author</role><aff><institution>Sichuan University</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lu</given-names></name><role specific-use="author">Author</role><aff><institution>University of Electronic Science and Technology of China</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Fei</surname><given-names>Ping</given-names></name><role specific-use="author">Author</role><aff><institution>Shanghai Jiao Tong University School of Medicine</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Qianchun</given-names></name><role specific-use="author">Author</role><aff><institution>University of Electronic Science and Technology of China</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Lulin</given-names></name><role specific-use="author">Author</role><aff><institution>University of Electronic Science and Technology of China</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Peiquan</given-names></name><role specific-use="author">Author</role><aff><institution>Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Zhenglin</given-names></name><role specific-use="author">Author</role><aff><institution>University of Electronic Science and Technology of China</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Xianjun</given-names></name><role specific-use="author">Author</role><aff><institution>University of Electronic Science and Technology of China</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>The author presents the discovery and characterization of CAPSL as a potential gene linked to Familial Exudative Vitreoretinopathy (FEVR), identifying one nonsense and one missense mutation within CAPSL in two distinct patient families afflicted by FEVR. Cell transfection assays suggest that the missense mutation adversely affects protein levels when overexpressed in cell cultures. Furthermore, conditionally knocking out CAPSL in vascular endothelial cells leads to compromised vascular development. The suppression of CAPSL in human retinal microvascular endothelial cells results in hindered tube formation, a decrease in cell proliferation, and disrupted cell polarity. Additionally, transcriptomic and proteomic profiling of these cells indicates alterations in the MYC pathway.</p><p>Strengths:</p><p>The study is nicely designed with a combination of in vivo and in vitro approaches, and the experimental results are good quality.</p></disp-quote><p>We thank the reviewer for the conclusion and positive comments.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>My reservations lie with the main assertion that CAPSL is associated with FEVR, as the genetic evidence from human studies appears relatively weak. Further careful examination of human genetics evidence in both patient cohorts and the general population will help to clarify. In light of human genetics, more caution needs to be exercised when interpreting results from mice and cell models and how is it related to the human patient phenotype.</p></disp-quote><p>We thank the reviewer for careful reading and constructive suggestion. we added several experiments to address the concern of reviewer are as follows:</p><p>(1) The pLI score of LOF allele of CAPSL is based of general population, among which Europeans account for ~77% and East Asians make up less than 3%. Since the FEVR families in this article all come from China, the pLI score may not be accurate. Of course, we will continue to collect FEVR pedigrees.</p><p>(2) We evaluated the phenotype of <italic>Capsl</italic> heterozygous mice at P5, and the results showed no overt difference in vascular progression, vessel density and branchpoints with littermate wildtype controls (Fig.S4). The lack of pronounced phenotype in FEVR heterozygous mice may be due to different sensitivity between human and mice. A similar example is LRP5 mutations associated with FEVR. Heterozygous mutations in LRP5 were reported in FEVR patients in multiple populations (PMID: 16929062, 33302760, 27486893, 35918671, 36411543). However, heterozygous Lrp5 knockout mice exhibited no visible angiogenic phenotype (PMID: 18263894). Corresponding description was added in the manuscript at page 6.</p><p>(3) We further assessed the angiogenic phenotype when angiogenesis almost complete at P21, and the resulted revealed no difference observed between Ctrl and CapsliECKO/iECKO mice (Fig.S5). And corresponding description was added in the manuscript at page 7.</p><p>(4) We evaluated the expression of MYC downstream genes in vivo using lung tissue form P35 Ctrl and _Capsl_iECKO/iECKO mice (Fig.S8). Consistent with the results from in vitro HRECs, _Capsl_iECKO/iECKO mice showed downregulated expression of MYC targets. And corresponding description was added in the manuscript at page 11.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>This work identifies two variants in CAPSL in two-generation familial exudative vitreoretinopathy (FEVR) pedigrees, and using a knockout mouse model, they link CAPSL to retinal vascular development and endothelial proliferation. Together, these findings suggest that the identified variants may be causative and that CAPSL is a new FEVR-associated gene.</p><p>Strengths:</p><p>The authors' data provides compelling evidence that loss of the poorly understood protein CAPSL can lead to reduced endothelial proliferation in mouse retina and suppression of MYC signaling in vitro, consistent with the disease seen in FEVR patients. The study is important, providing new potential targets and mechanisms for this poorly understood disease. The paper is clearly written, and the data generally support the author's hypotheses.</p></disp-quote><p>We thank the reviewer for the conclusion and positive comments.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>(1) Both pedigrees described appear to suggest that heterozygosity is sufficient to cause disease, but authors have not explored the phenotype of Capsl heterozygous mice. Do these animals have reduced angiogenesis similar to KOs? Furthermore, while the p.R30X variant protein does not appear to be expressed in vitro, a substantial amount of p.L83F was detectable by western blot and appeared to be at the normal molecular weight. Given that the full knockout mouse phenotype is comparatively mild, it is unclear whether this modest reduction in protein expression would be sufficient to cause FEVR - especially as the affected individuals still have one healthy copy of the gene. Additional studies are needed to determine if these variants alter protein trafficking or localization in addition to expression, and if they can act in a dominant negative fashion.</p></disp-quote><p>We thank the reviewer for the suggestion. We evaluated the phenotype of Capsl heterozygous mice at P5 (Fig.S4), and the results showed no overt difference in angiogenesis compared with littermate control mice.</p><p>We transfected CAPSL wild-type plasmid, p.R30X mutant plasmid and p.L83F mutant plasmid into 293T cells to assess the intracellular localization change of CAPSL mutant proteins (Fig.S1). The result showed that the point mutation did not affect the localization of the mutated protein, and corresponding description was added in the manuscript at page 5.</p><disp-quote content-type="editor-comment"><p>(2) The manuscript nicely shows that loss of CAPSL leads to suppressed MYC signaling in vitro. However, given that endothelial MYC is regulated by numerous pathways and proteins, including FOXO1, VEGFR2, ERK, and Notch, and reduced MYC signaling is generally associated with reduced endothelial proliferation, this finding provides little insight into the mechanism of CAPSL in regulating endothelial proliferation. It would be helpful to explore the status of these other pathways in knockdown cells but as the authors provide only GSEA results and not the underlying data behind their RNA seq results, it is difficult for the reader to understand the full phenotype. Volcano plots or similar representations of the underlying expression data in Figures 6 and 7 as well as supplemental datasets showing the differentially regulated genes should be included. In addition, while the paper beautifully characterizes the delayed retinal angiogenesis phenotype in CAPSL knockout mice, the authors do not return to that model to confirm their in vitro findings.</p></disp-quote><p>We thank the reviewer for the suggestion. Although endothelial MYC can be regulated by FOXO1, VEGFR2, ERK, and Notch signaling pathway, these pathways are not enriched in the RNA seq data of CAPSL-depleted HRECs. This suggests that the down regulated MYC targets may not be influenced by the signaling pathway mentioned above. RNA-seq raw data have been uploaded to the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa/browse/HRA010305">https://ngdc.cncb.ac.cn/gsa/browse/HRA010305</ext-link>) and proteomic profiling raw data have been uploaded to the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive">https://www.ebi.ac.uk/pride/archive</ext-link>), and the assigned accession number was PXD051696. Corresponding description was added in the manuscript at page 20-21. The datasets represent the differentially regulated genes in Figure 6 and 7 were listed at Dataset S1 and S2.</p><disp-quote content-type="editor-comment"><p>(3) In Figure S2D, the result of this vascular leak experiment is unconvincing as no dye can be seen in the vessels. What are the kinetics for biocytin tracers to enter the bloodstream after IP injection? Why did the authors choose the IP instead of the IV route for this experiment? Differences in the uptake of the eye after IP injection could confound the results, especially in the context of a model with vascular dysfunction as here.</p></disp-quote><p>We thank the reviewer for suggestion. In Figure S2D (now Fig.S6D), we used a non-representative image to show vascular leakage. We replaced the images with more representative ones. We are sorry that we are not clear about the kinetics for biocytin tracers to enter the bloodstream after IP injection. Since the experiment was carried out on mice at P5, it is not feasible to do IV injection in P5 neonatal mice. We followed the methods described in the previous study involving mice of same age (PMID:35361685).</p><disp-quote content-type="editor-comment"><p>(4) In Figure 5, it is unclear how filipodia and tip cells were identified and selected for quantification. The panels do not include nuclear or tip cell-specific markers that would allow quantification of individual tip cells, and in Figure 5C it appears that some filipodia are not highlighted in the mutant panel.</p></disp-quote><p>We thank the reviewer for the comments. In Figure 5, we used HRECs to examine the cell proliferation, migration and polarity in vitro, and therefore there is no distinction between tip cells and stalk cells. The quantification of filopodia/lamellipodia was performed as previous studies (PMID: 30783090, PMID: 28805663). In briefly, wound scratch was performed on confluent layers of transfected HRECs, and 9 hours after initiating cell migration by scratch, cells were fixed and stained with phalloidin. Cells at the edge of wound were considered as leader cells and quantified for number of filopodia/lamellipodia.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public Review):</bold></p><p>Summary:</p><p>This manuscript by Liu et al. presents a case that CAPSL mutations are a cause of familial exudative vitreoretinopathy (FEVR). Attention was initially focused on the CAPSL gene from whole exome sequence analysis of two small families. The follow-up analyses included studies in which CAPSL was manipulated in endothelial cells of mice and multiple iterations of molecular and cellular analyses. Together, the data show that CAPSL influences endothelial cell proliferation and migration. Molecularly, transcriptomic and proteomic analyses suggest that CAPSL influences many genes/proteins that are also downstream targets of MYC and may be important to the mechanisms.</p><p>Strengths:</p><p>This multi-pronged approach found a previously unknown function for CAPSLs in endothelial cells and pointed at MYC pathways as high-quality candidates in the mechanism.</p><p>Weaknesses:</p><p>Two issues shape the overall impact for me. First, the unreported population frequency of the variants in the manuscript makes it unclear if CAPSL should be considered an interesting candidate possibly contributing to FEVR, or possibly a cause. Second, it is unclear if the identified variants act dominantly, as indicated in the pedigrees. The studies in mice utilized homozygotes for an endothelial cell-specific knockout, leaving uncertainty about what phenotypes might be observed if mice heterozygous for a ubiquitous knockout had instead been studied.</p><p>In my opinion, the following scientific issues are specific weaknesses that should be addressed:</p><p>(1) Please state in the manuscript the number of FEVR families that were studied by WES. Please also describe if the families had been selected for the absence of known mutations, and/or what percentage lack known pathogenic variants.</p></disp-quote><p>We thank the reviewer for thoughtful comments. 120 FEVR families were studied by WES and we added corresponding description in the manuscript at page 4.</p><disp-quote content-type="editor-comment"><p>(2) A better clinical description of family 3104 would enhance the manuscript, especially the father. It is unclear what &quot;manifested with FEVR symptoms, according to the medical records&quot; means. Was the father diagnosed with FEVR? If the father has some iteration of a mild case, please describe it in more detail. If the lack of clinical images in the figure is indicative of a lack of medical documentation, please note this in the manuscript.</p></disp-quote><p>We thank the reviewer for thoughtful comments. The father of family 3104 has also been identified as a carrier of this heterozygous variant, manifested with FEVR symptoms, according to the medical records. Nevertheless, clinical examination images are presently unavailable. We added corresponding description in the manuscript at page 5.</p><disp-quote content-type="editor-comment"><p>(3) The TGA stop codon can in some instances also influence splicing (PMID: 38012313). Please add a bioinformatic assessment of splicing prediction to the assays and report its output in the manuscript.</p></disp-quote><p>We thank the reviewer for thoughtful comments. We predicted the splicing of c.88C&gt;T variant of CAPSL using MaxEntScan (<ext-link ext-link-type="uri" xlink:href="http://hollywood.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html">http://hollywood.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html</ext-link>) and SpliceTool (<ext-link ext-link-type="uri" xlink:href="https://rddc.tsinghua-gd.org/ai">https://rddc.tsinghua-gd.org/ai</ext-link>) (Fig.S2). MaxEntScan and SpliceTool were used to predict the impact of TGA stop codon of c.88C&gt;T variant on the formation of a cryptic donor splice site.</p><disp-quote content-type="editor-comment"><p>(4) More details regarding utilizing a &quot;loxp-flanked allele of CAPSL&quot; are needed. Is this an existing allele, if so, what is the allele and citation? If new (as suggested by S1), the newly generated CAPSL mutant mouse strain needs to be entered into the MGI database and assigned an official allele name - which should then be utilized in the manuscript and who generated the strain (presumably a core or company?) must be described.</p></disp-quote><p>We added detailed description of Capsl flxoed allele to Method section on page 14-15: “Capslloxp/+ model was generated using the CRISPR/Cas9 nickase technique by Viewsolid Biotechology (Beijing, China) in C57BL/6J background and named Capslem1zxj. The genomic RNA (gRNA) sequence was as follows: Capsl-L gRNA: <named-content content-type="sequence">5’-CTATCCCAA TTGTGCTCCTGG-3’</named-content>; Capsl-R gRNA: <named-content content-type="sequence">5’-TGGGACTCATGGTTCTAGAGG-3’</named-content>. ”</p><disp-quote content-type="editor-comment"><p>(5) The statement in the methods &quot;All mice used in the study were on a C57BL/6J genetic background,&quot; should be better defined. Was the new allele generated on a pure C57BL/6J genetic background, or bred to be some level of congenic? If congenic, to what generation? If unknown, please either test and report the homogeneity of the background, or consult with nomenclature experts (such as available through MGI) to adopt the appropriate F?+NX type designation. This also pertains to the Pdgfb-iCreER mice, which reference 43 describes as having been generated in an F2 population of C57BL/6 X CBA and did not designate the sub-strain of C57BL/6 mice. It is important because one of the explanations for missing heritability in FEVR may be a high level of dependence on genetic background. From the information in the current description, it is also not inherently obvious that the mice studied did not harbor confounding mutations such as rd1 or rd8.</p></disp-quote><p>We thank the reviewer for suggestion. We added the following description to “Mouse model and genotyping” method section on page 14. “Capslloxp/+ model was generated using the CRISPR/Cas9 nickase technique by Viewsolid Biotechology (Beijing, China) in C57BL/6J background and named Capslem1zxj. The genomic RNA (gRNA) sequence was as follows: Capsl-L gRNA: <named-content content-type="sequence">5’-CTATCCCAA TTGTGCTCCTGG-3’</named-content>; Capsl-R gRNA: <named-content content-type="sequence">5’-TGGGACTCATGGTTCTAGAGG-3’</named-content>. Pdgfb-iCreER[43] transgenic mice on a mixed background of C57BL/6 and CBA was obtainted from Dr. Marcus Fruttiger and backcrossed to background for 6 generations. Capslloxp/+ mice were bred with Pdgfb-iCreER[43] transgenic mice to generate Capslloxp/loxp, Pdgfb-iCreER mice.” Sanger sequencing was performed on experimental mice to identify whether they harbor confounding mutations such as Pde6b or Crb1. The results showed the mice did not harbor confounding mutations (Fig.S9) and corresponding description was added in the manuscript at page 15.</p><disp-quote content-type="editor-comment"><p>(6) In my opinion, more experimental detail is needed regarding Figures 2 and 3. How many fields, of how many retinas and mice were analyzed in Figure 2? How many mice were assessed in Figure 3?</p></disp-quote><p>We thank the reviewer for thoughtful comments. We have already presented the detailed information in the manuscript, please refer to the “Methods-Quantification of retinal parameters” section for experimental details.</p><disp-quote content-type="editor-comment"><p>(7) I suggest adding into the methods whether P-values were corrected for multiple tests.</p></disp-quote><p>We thank the reviewer for suggestion. Actually, the statistical analysis was performed using unpaired Student’s t-test for comparison between two groups or one-way ANOVA followed by Dunnett multiple comparison test for comparison of multiple groups. The above description was added to “Methods-Image acquisition and statistical analysis” section to make it clear.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewing Editor (Recommendations For The Authors):</bold></p><p>In summary, the following concerns should addressing reviewers' concerns as outlined below could bolster the evidence from &quot;solid&quot; to &quot;convincing&quot; and further strengthen the study's impact.</p><p>(1) Analysis of the phenotype in CAPSLheterozygous mice, as highlighted by all 3 reviews.</p><p>We thank the editor for thoughtful comments. The phenotype analysis of <italic>Capsl</italic> heterozygous mice was added to Fig.S4, with the corresponding description provided at page 6.</p><p>(2) Analysis of Capsl KO mice to determine if the pathways identified in vitro are modified (as suggested by reviewers 1 &amp; 2).</p></disp-quote><p>We thank the editor for suggestion. In Fig.S7, RT-qPCR was performed on lung tissues from <italic>Capsl</italic> Ctrl and KO mice to validate the expression of MYC targets in vivo. And the result indicated that the downstream targets of MYC signaling were also downregulated in vivo, consistent with the <italic>in vitro</italic> findings.</p><disp-quote content-type="editor-comment"><p>(3) Additional description of the genetic pedigrees and variants to address the points raised by reviewer #3.</p></disp-quote><p>We thank the editor for suggestion. The father of family 3104 has also been identified as a carrier of this heterozygous variant, manifested with FEVR symptoms, according to the medical records. Nevertheless, clinical examination data are presently unavailable. We added corresponding description in the manuscript page 5.</p><disp-quote content-type="editor-comment"><p>(4) Validation of the identified protein variants, especially L83F which appears to be expressed at a near normal level. Are these proteins mislocalized, do the variants to interfere with sites of known or predicted protein-protein interactions, could they act in a dominant-negative fashion by aggregation with co-expressed WT protein etc. Given the comparatively weak genetic data, additional validation is required to establish plausibility of CAPSL as a FEVR gene.</p></disp-quote><p>We thank the editor for suggestion. As substantial amount of p.L83F was detectable at normal molecular weight, we further investigated whether this variant affects protein localization. Fig.S1, immunocytochemistry results indicated that this variant does not affect the subcellular localization of the protein.</p><disp-quote content-type="editor-comment"><p>(5) Improved description of experimental details and statistical analyses as outlined by reviewer #3.</p></disp-quote><p>We thank the editor for suggestion. The more detailed information about <italic>Capsl</italic> mice was added in the manuscript at page 14-15. The experimental details regarding Figure 2 and Figure 3 have already presented in the “Methods-Quantification of retina parameters” section in the manuscript at page 19-20. And the statistical analysis was performed using unpaired Student’s t-test for comparison between two groups or one-way ANOVA followed by Dunnett multiple comparison test for comparison of multiple groups. The above description was added to “Methods-Image acquisition and statistical analysis” section at page 21 to make it clear.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>My reservations lie with the main assertion that CAPSL is associated with FEVR, as the genetic evidence from human studies appears relatively weak. My concerns are as follows:</p><p>(1) The molecular characterization of the identified mutations suggests a loss of function (LOF). Notably, in one family, both the father and son exhibit the FEVR phenotype and share the LOF mutation, suggesting a dominant mode of inheritance. However, the prevalence of the LOF allele of CAPSL in the general population is high, and its pLI score is 0, according to the GNOMAD database. This raises doubts about the LOF variant of CAPSL being causative for FEVR.</p></disp-quote><p>We thank the reviewer for recommendation. The pLI score of LOF allele of CAPSL is based of general population, among which Europeans account for ~77% and East Asians make up less than 3%. Since the FEVR families in this article all come from China, the pLI score may not be accurate. Of course, we will continue to collect FEVR pedigrees and screen for CAPSL mutations.</p><disp-quote content-type="editor-comment"><p>(2) In the conditional knockout study, a delay in vascular development is observed in the retina up to P14. What the phenotype looks like in adult mice and whether it replicates the human FEVR phenotype?</p></disp-quote><p>We thank the reviewer for recommendation. We further assessed the phenotype when angiogenesis almost complete at P21, the resulted showed no difference in Ctrl and CapsliECKO/iECKO mice (Fig.S5). And corresponding description was added in the manuscript at page 7.</p><disp-quote content-type="editor-comment"><p>(3) The conditional knockout mice lack both alleles of CAPSL. The phenotype resulting from the knockout of a single allele needs investigation to align with observed human phenotypes and genetic data.</p></disp-quote><p>We thank the reviewer for recommendation. The phenotype of Capsl heterozygous mice at P5 showed no overt difference in vascular progression, vessel density and branchpoints with littermate wildtype controls (Fig.S4). The lack of pronounced phenotype in FEVR heterozygous mice may be due to different sensitivity between human and mice. A similar example is LRP5 mutations associated with FEVR. Heterozygous mutations in LRP5 were reported in FEVR patients in multiple populations. However, heterozygous Lrp5 mice exhibited no visible angiogenic phenotype (PMID: 18263894).</p><disp-quote content-type="editor-comment"><p>(4) The MYC pathway has been identified as influenced by CAPSL. Whether MYC downregulation is observed in the mouse model in vivo?</p></disp-quote><p>We thank the reviewer for recommendation. MYC expression was identified at both mRNA and protein level in Figure S8, and corresponding description was added in the manuscript at page 11.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>Minor comments:</p><p>(1) While authors note that little is known about CAPSL protein function, more introductory detail about the protein (structure, domains intracellular localization etc) and additional discussion on potential mechanisms would aid the reader in interpreting the findings and model.</p></disp-quote><p>We thank the reviewer for recommendation. The subcellular localization of the CAPSL protein is distributed in both the nucleus and cytoplasm (<ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org/">https://www.proteinatlas.org/</ext-link>). The immunochemistry analysis confirmed that CAPSL protein is expressed in both the cell nucleus and cytoplasm (Fig.S1). And corresponding description was added in the manuscript at page 5.</p><disp-quote content-type="editor-comment"><p>(2) Pg 7 states that Capsl knockout mainly leads to &quot;...defects in retinal vascular ECs rather than other vascular cells.&quot;. Consider rephrasing to describe &quot;other vasculature-associated cells&quot;, as no vascular cells outside the retina were examined in the manuscript.</p></disp-quote><p>We thank the reviewer for recommendation. We rephrased the &quot;...defects in retinal vascular ECs rather than other vascular cells.&quot; into &quot;...defects in retinal vascular ECs rather than other vasculature-associated cells&quot; at page 8.</p><disp-quote content-type="editor-comment"><p>(3) The manuscript is well written but contains numerous typos. E.g. &quot;&quot; (Pg 14), &quot;MCY signaling axis&quot; (figure 6 legend), &quot;shCAPAL&quot; (figure 5 K). Please correct these, and search carefully for others.</p></disp-quote><p>We are sorry for the careless mistakes we made, and we have checked the manuscript and correct these mistakes.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>The following are somewhat grammatical, but significant issues, that I feel should be addressed before making the pre-print final:</p><p>(1) Perhaps the largest issue with the manuscript to me is whether CAPSL is an interesting candidate (as stated repeatedly) or causative of FEVR. Within the scope of what is feasible, this is a challenging problem. Since the publication of the pre-print, it would be great if another group independently reported the detection of mutations specifically in FEVR patients. That lacking, meaningful additions to the manuscript that I'd recommend are the inclusion of a paragraph on caveats of the study and reporting the allele frequencies based on public databases. As the authors know the data better than anyone and will have invested thought into the implications, they are the ones best positioned to alert the field to the study's limitations - amongst them- the factors that might practically distinguish whether CAPSL is a candidate or cause.</p></disp-quote><p>We thank the reviewer for recommendation. We will collect more samples from FEVR families and screen for other mutation sites within the CAPSL gene in further studies.</p><disp-quote content-type="editor-comment"><p>(2) It is unclear why the modeling with mice did not attempt to recapitulate the observations in humans, i.e., why were heterozygotes for a ubiquitous knockout not studied? Any data with heterozygotes, or ubiquitous alleles (which would be easier to generate than the strain studied) should be shared in the manuscript. If no such data exists, this reviewer would find it a worthwhile new experiment to add, but it is appreciated that new experiments are sometimes beyond the scope of what is possible. At the least, this would be worthwhile to discuss in the requested caveats paragraph of the discussion.</p></disp-quote><p>We thank the reviewer for recommendation. We evaluated the phenotype of Capsl heterozygous mice at P5, and the results showed no overt difference in vascular progression, vessel density and branchpoints with littermate wildtype controls (Fig.S4). The lack of pronounced phenotype in FEVR heterozygous mice may be due to different sensitivity between human and mice. For example, heterozygous Lrp5 mice exhibited no visible angiogenic phenotype (PMID: 18263894). Corresponding description was added in the manuscript at page 6.</p><disp-quote content-type="editor-comment"><p>(3) The statement in the Abstract &quot;which provides invaluable information for genetic counseling and prenatal diagnosis of FEVR&quot; should be toned down, better supported, or rephrased. This appears to be the 18th disease-associated gene for FEVR, with variants identified in 4 patients of the same ethnicity. In my opinion, the word &quot;invaluable&quot; is currently overstated.</p></disp-quote><p>We thank the reviewer for recommendation. We have changed &quot;which provides invaluable information for genetic counseling and prenatal diagnosis of FEVR&quot; into &quot;which provides valuable information for genetic counseling and prenatal diagnosis of FEVR&quot; in the abstract.</p><disp-quote content-type="editor-comment"><p>(4) The transcriptomic and proteomic data should be deposited into a public repository and accession numbers added to the manuscript.</p></disp-quote><p>We thank the reviewer for recommendation. We have uploaded the raw data of transcriptomic and proteomic to the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa/browse/HRA010305">https://ngdc.cncb.ac.cn/gsa/browse/HRA010305</ext-link>) and the Genome Sequence Archive (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive">https://www.ebi.ac.uk/pride/archive</ext-link>), respectively.</p><disp-quote content-type="editor-comment"><p>(5) The links to MYC are over-stated in the title &quot;through the MYC axis&quot;, the abstract &quot;CAPSL function causes FEVR through MYC axis&quot;, and the discussion &quot;we demonstrated that the defects in CAPSL affect EC function by down-regulating the MYC signaling cascade&quot;. The links to MYC are entirely by association, there were no experiments testing that the transcriptomic and proteomic changes observed were determinative of the CAPSL-mediated phenotype. It seems appropriate to conjecture that these changes are important, but the above statements all need to be altered and conjectures need to be clearly identified as such.</p></disp-quote><p>We are sorry to overstate the link between CAPSL-mediated phenotype and MYC axis in the abstract and discussion sections, and we have altered the statements in these sections to make it more logical. For example, we changed “This study also reveals that compromised CAPSL function causes FEVR through MYC axis, shedding light on the potential involvement of MYC signaling in the pathogenesis of FEVR.” into “This study also reveals that compromised CAPSL function causes FEVR may through MYC axis, shedding light on the potential involvement of MYC signaling in the pathogenesis of FEVR.” in the abstract. And in the discussion we changed “…cause FEVR through inactivating MYC signaling, expanding FEVR-involved signaling pathway and providing a potential therapeutic target for the intervention of FEVR” to “…cause FEVR may through inactivating MYC signaling, expanding FEVR-involved signaling pathway and providing a potential therapeutic target for the intervention of FEVR”.</p><disp-quote content-type="editor-comment"><p>(6) Finally, I suggest that the following grammatical issues in the pre-print be corrected before making the pre-print final:</p></disp-quote><p>We have checked the manuscript and correct these mistakes.</p><disp-quote content-type="editor-comment"><p>(a) p2. Suggest rewriting the sentence &quot;Nevertheless, the molecular mechanisms by which CAPSL regulates cell processes and signaling cascades have yet to be elucidated.&quot; The preceding sentences only state that CASPL is a candidate in another disease - the word &quot;nevertheless&quot; seems to reflect a logic that isn't described.</p></disp-quote><p>We have checked the manuscript and correct these mistakes.</p><disp-quote content-type="editor-comment"><p>(b) p5. Please correct the grammar &quot;We, generated an inducible&quot;</p></disp-quote><p>We corrected this mistake.</p><disp-quote content-type="editor-comment"><p>(c) p5. Suggest rephrasing &quot;impairing CAPSL expression.&quot; The word &quot;expression&quot; is often used in reference to transcription. To avoid confusion, something such as &quot;eliminating or reducing protein abundance&quot; might be better.</p></disp-quote><p>We corrected this mistake.</p><disp-quote content-type="editor-comment"><p>(d) p6. Please correct the grammar &quot;As expected, the radial vascular growth, as well as vessel density and vascular branching, are dramatically reduced in...&quot; - note subject-verb agreement issue</p></disp-quote><p>We corrected this mistake.</p><disp-quote content-type="editor-comment"><p>(e) Figure 3 legend - correct &quot;(A) Hyloaid vessels&quot;</p></disp-quote><p>We corrected this mistake.</p></body></sub-article></article>